Home The Word Brain My Amedeo FAQ Privacy About   


2049 Chinese

The 20K Word Road to Mandarin Proficiency

By B. S. Kamps et al.


  Chronic Heart Failure

  Free Subscription


Articles published in Int J Cardiol

Retrieve available abstracts of 492 articles:
HTML format



Single Articles


    September 2024
  1. HUA L
    Reply to "Assessing the clinical utility of the HFpEF nomogram: A call for broader validation".
    Int J Cardiol. 2024;410:132214.
    PubMed    


    August 2024
  2. ANSARI RAMANDI MM, Hendriks PM, Voors AA, van den Bosch AE, et al
    Bioactive adrenomedullin as a marker of congestion and disease progression in patients with a systemic right ventricle.
    Int J Cardiol. 2024;408:132107.
    PubMed     Abstract available


    July 2024
  3. FU K, Yang Z, Wang N, Dong Y, et al
    Recurrence of left ventricular systolic dysfunction and its risk factors in heart failure with improved ejection fraction patients receiving guideline-directed medical therapy: A trajectory analysis based on echocardiography.
    Int J Cardiol. 2024 Jul 17:132370. doi: 10.1016/j.ijcard.2024.132370.
    PubMed     Abstract available


  4. HUANG H, Fu B, Long T, Yu Y, et al
    Implication of geriatric nutritional risk index on treatment response and long-term prognosis in patients with cardiac resynchronization therapy.
    Int J Cardiol. 2024;407:132064.
    PubMed     Abstract available


  5. PINTALHAO M, Vasques-Novoa F, Barros AS, Lourenco P, et al
    Prognostic association of circulating relaxin-2 in acute heart failure.
    Int J Cardiol. 2024 Jul 11:132358. doi: 10.1016/j.ijcard.2024.132358.
    PubMed     Abstract available


  6. ZHANG L, Liu Z, Zeng J, Wu M, et al
    Long-term effects of air quality on hospital readmission for heart failure in patients with acute myocardial infarction.
    Int J Cardiol. 2024 Jul 6:132344. doi: 10.1016/j.ijcard.2024.132344.
    PubMed     Abstract available


  7. DE PONTI C, Bonaventura A
    Bioelectrical impedance analysis for early recognition of fluid congestion in heart failure: Is it the best tool?
    Int J Cardiol. 2024 Jul 5:132314. doi: 10.1016/j.ijcard.2024.132314.
    PubMed    


  8. MEGURO T
    Diversity in heart failure management: Quo Vadis guideline-directed medical therapy?
    Int J Cardiol. 2024 Jul 5:132325. doi: 10.1016/j.ijcard.2024.132325.
    PubMed    


  9. DE ALMEIDA PINHO I, Pimentel MJ, Oliveira C, Matos MI, et al
    Office- versus home-based evaluation of quality of life in heart failure with reduced ejection fraction: A randomized study.
    Int J Cardiol. 2024 Jul 4:132341. doi: 10.1016/j.ijcard.2024.132341.
    PubMed     Abstract available


  10. TERSALVI G, Bossard M, Aeschbacher S, Wiencierz A, et al
    Prevalence and outcomes of heart failure phenotypes in patients with atrial fibrillation.
    Int J Cardiol. 2024 Jul 2:132320. doi: 10.1016/j.ijcard.2024.132320.
    PubMed     Abstract available


  11. ALBULUSHI A
    Assessing the clinical utility of the HFpEF nomogram: A call for broader validation.
    Int J Cardiol. 2024;406:132038.
    PubMed    


  12. NOGIMORI Y, Sato K, Takamizawa K, Ogawa Y, et al
    Prediction of adverse cardiovascular events in children using artificial intelligence-based electrocardiogram.
    Int J Cardiol. 2024;406:132019.
    PubMed     Abstract available


    June 2024
  13. ESPERSEN C, Campbell RT, Claggett BL, Biering-Sorensen T, et al
    Reply to: Instrumental outcome modifiers to be considered among patients with acute heart failure.
    Int J Cardiol. 2024 Jun 29:132310. doi: 10.1016/j.ijcard.2024.132310.
    PubMed    


  14. TIMOTEO AT, Barbas Albuquerque F, Lacerda Teixeira B
    Pericardium, epicardial adipose tissue, and heart failure with preserved ejection fraction: Pathophysiology, quantification and treatment target.
    Int J Cardiol. 2024;412:132303.
    PubMed     Abstract available


  15. ABDIN A, Bohm M, Shahim B, Karlstrom P, et al
    Heart failure with preserved ejection fraction epidemiology, pathophysiology, diagnosis and treatment strategies.
    Int J Cardiol. 2024 Jun 27:132304. doi: 10.1016/j.ijcard.2024.132304.
    PubMed     Abstract available


  16. AIMO A, Arzilli C, Castiglione V, Morfino P, et al
    Safety and efficacy of levosimendan in patients with cardiac amyloidosis.
    Int J Cardiol. 2024;405:131963.
    PubMed     Abstract available


  17. FORTUNI F, Tavazzi L, Ciliberti G
    Digital health in heart failure: Empowering physicians to enhance patient care.
    Int J Cardiol. 2024 Jun 15:132261. doi: 10.1016/j.ijcard.2024.132261.
    PubMed    


  18. FERREIRA JP, Zannad F, Solomon SD
    Reply to the letter entitled "Inflammation in Heart Failure with Preserved Ejection Fraction: A Bystander or A Participant?" by Zhong M and Yan X.
    Int J Cardiol. 2024 Jun 14:132278. doi: 10.1016/j.ijcard.2024.132278.
    PubMed    


  19. KAMAR SA, Oostdijk B, Andrzejczyk K, Constantinescu A, et al
    Temporal evolution of anxiety and depression in chronic heart failure and its association with clinical outcome.
    Int J Cardiol. 2024 Jun 14:132274. doi: 10.1016/j.ijcard.2024.132274.
    PubMed     Abstract available


  20. DAUNGSUPAWONG H, Wiwanitkit V
    Comment on "Accuracy and consistency of online large language model-based artificial intelligence chat platforms in answering patients' questions about heart failure: Doi: 10.1016/j.ijcard.2024.132115".
    Int J Cardiol. 2024;410:132242.
    PubMed    


  21. KRITTAYAPHONG R, Yingchoncharoen T, Puwanant S, Boonyapiphat T, et al
    Reassessing heart failure therapy in Thailand: Patient insights and treatment outcomes from the Thai heart failure registry.
    Int J Cardiol. 2024 Jun 4:132235. doi: 10.1016/j.ijcard.2024.132235.
    PubMed     Abstract available


  22. CAI Q, Li Q, Zhong S, Chen M, et al
    Ultrasound-targeted microbubble destruction rapidly improves left ventricular function in rats with ischemic cardiac dysfunction.
    Int J Cardiol. 2024;404:131943.
    PubMed     Abstract available


  23. NABESHIMA Y, Tanaka A, Node K
    Sweet relationship between SGLT2 inhibition and heart failure.
    Int J Cardiol. 2024;410:132223.
    PubMed    


    May 2024
  24. LEE S, Battumur B, Lee JE, Park SH, et al
    Assessing lung fluid status using noninvasive bioelectrical impedance analysis in patients with acute heart failure: A pilot study.
    Int J Cardiol. 2024;409:132205.
    PubMed     Abstract available


  25. TADA A, Nagai T, Anzai T
    Is growth differentiation factor-15 a useful biomarker for chronic heart failure across body size?
    Int J Cardiol. 2024 May 23:132204. doi: 10.1016/j.ijcard.2024.132204.
    PubMed    


  26. TAKEUCHI S, Kohno T, Goda A, Shiraishi Y, et al
    Renin-angiotensin system inhibitors for patients with mild or moderate chronic kidney disease and heart failure with mildly reduced or preserved ejection fraction.
    Int J Cardiol. 2024;409:132190.
    PubMed     Abstract available


  27. LIU H, Xu G
    SNHG1/miR-15a-5p/Drd5: A potential mechanism for treating heart failure.
    Int J Cardiol. 2024;409:132188.
    PubMed    


  28. TADAFUMI S
    Pulmonary fluid redistribution during exercise and recovery in chronic heart failure.
    Int J Cardiol. 2024 May 14:132173. doi: 10.1016/j.ijcard.2024.132173.
    PubMed    


  29. KAWAI A, Nagatomo Y, Yukino-Iwashita M, Ikegami Y, et al
    Supra-normal and mildly reduced ejection fraction in women -An overlooked vulnerable subpopulation in heart failure.
    Int J Cardiol. 2024 May 12:132166. doi: 10.1016/j.ijcard.2024.132166.
    PubMed     Abstract available


  30. FEDERICA P, Samantha B, Davide A, Lucia C, et al
    Serum uric acid to eGFR ratio correlates with adverse outcomes in elderly hospitalized for acute heart failure.
    Int J Cardiol. 2024 May 11:132160. doi: 10.1016/j.ijcard.2024.132160.
    PubMed     Abstract available


  31. HUNG KC, Chao CT
    Instrumental outcome modifiers to be considered among patients with acute heart failure.
    Int J Cardiol. 2024;408:132145.
    PubMed    


  32. ZHONG M, Yan X
    Inflammation in heart failure with preserved ejection fraction: A bystander or a participant?
    Int J Cardiol. 2024;408:132144.
    PubMed    


  33. COLLUOGLU IT, Celik A, Ata N, Ural D, et al
    Deciphering mortality risk of diabetes medications in heart failure patients with diabetes mellitus under triple guideline-directed medical therapy.
    Int J Cardiol. 2024;407:132109.
    PubMed     Abstract available


  34. ALBULUSHI A, Al Kindi DI, Moawwad N, Kamel AM, et al
    Digital health technologies in enhancing patient and caregiver engagement in heart failure management: Opportunities and challenges.
    Int J Cardiol. 2024 May 2:132116. doi: 10.1016/j.ijcard.2024.132116.
    PubMed     Abstract available


  35. SPERLONGANO S, Benfari G, Ilardi F, Lisi M, et al
    Role of speckle tracking echocardiography beyond current guidelines in cardiac resynchronization therapy.
    Int J Cardiol. 2024;402:131885.
    PubMed     Abstract available


    April 2024
  36. KOZAILY E, Geagea M, Akdogan ER, Atkins J, et al
    Accuracy and consistency of online large language model-based artificial intelligence chat platforms in answering patients' questions about heart failure.
    Int J Cardiol. 2024 Apr 30:132115. doi: 10.1016/j.ijcard.2024.132115.
    PubMed     Abstract available


  37. TERAMOTO K, Nochioka K, Sakata Y, Kato ET, et al
    Growth differentiation factor-1?5 and metabolic features in chronic heart failure: Insights from the SUPPORT Trial -GDF15 across the BMI spectrum.
    Int J Cardiol. 2024 Apr 23:132093. doi: 10.1016/j.ijcard.2024.132093.
    PubMed     Abstract available


  38. CHEW-HARRIS J, Frampton C, Greer C, Appleby S, et al
    Prognostic performance of soluble urokinase plasminogen activator receptor for heart failure or mortality in Western and Asian patients with acute breathlessness.
    Int J Cardiol. 2024 Apr 19:132071. doi: 10.1016/j.ijcard.2024.132071.
    PubMed     Abstract available


  39. PEZZUTO B, Contini M, Berna G, Galotta A, et al
    Dynamic trend of lung fluid movement during exercise in heart failure: From lung imaging to alveolar-capillary membrane function.
    Int J Cardiol. 2024 Apr 19:132041. doi: 10.1016/j.ijcard.2024.132041.
    PubMed     Abstract available


  40. HONG Y, Gao Z, Wei H, Wei Y, et al
    Bi-directional association of body size and composition with heart failure: A Mendelian randomization study.
    Int J Cardiol. 2024 Apr 19:132069. doi: 10.1016/j.ijcard.2024.132069.
    PubMed     Abstract available


  41. JONG CB, Lu TS, Chen JW
    Reply to comment on "Subclinical myocardial injury increases the risk of heart failure in patients with and without type 2 diabetes post-acute coronary syndrome".
    Int J Cardiol. 2024 Apr 10:132031. doi: 10.1016/j.ijcard.2024.132031.
    PubMed    


  42. ESPERSEN C, Campbell RT, Claggett BL, Lewis EF, et al
    Predictors of heart failure readmission and all-cause mortality in patients with acute heart failure.
    Int J Cardiol. 2024 Apr 8:132036. doi: 10.1016/j.ijcard.2024.132036.
    PubMed     Abstract available


  43. GLINGE C, Rossetti S, Oestergaard LB, Stampe NK, et al
    Familial clustering of unexplained heart failure - A Danish nationwide cohort study.
    Int J Cardiol. 2024 Apr 5:132028. doi: 10.1016/j.ijcard.2024.132028.
    PubMed     Abstract available


  44. NAKAO M, Nagai T, Anzai T
    Iron supplementation is a residual piece of management in Asian patients with heart failure?
    Int J Cardiol. 2024 Apr 4:132014. doi: 10.1016/j.ijcard.2024.132014.
    PubMed    


  45. DE MICHIELI L, Stoppa G, Sinigiani G, Previato L, et al
    Hospitalization-based epidemiology of systemic and cardiac amyloidosis in the Veneto Region, Italy.
    Int J Cardiol. 2024;400:131804.
    PubMed     Abstract available


  46. DE SA MARCHI MF, van den Dorpel M, Calomeni P, Chatterjee S, et al
    Comparative analysis of different risk prediction tools after mitral Transcatheter edge-to-edge repair.
    Int J Cardiol. 2024;400:131768.
    PubMed     Abstract available


  47. GARCIA-MOLL X, Lopez L
    Safety of sacubitril/valsartan among older adults. Where real world data meet clinical trials results.
    Int J Cardiol. 2024;400:131706.
    PubMed    


    March 2024
  48. CHENG Y, Zhang Q
    Comment on "Subclinical myocardial injury increases the risk of heart failure in patients with and without type 2 diabetes post-acute coronary syndrome".
    Int J Cardiol. 2024 Mar 26:131979. doi: 10.1016/j.ijcard.2024.131979.
    PubMed    


  49. YAO L, Gong X, Liu Y, Hao K, et al
    The miR-195-3p/BDNF axis is a promising therapeutic for heart failure.
    Int J Cardiol. 2024 Mar 22:131991. doi: 10.1016/j.ijcard.2024.131991.
    PubMed    


  50. CARIGI S, Gentile P, Gori M, Tinti D, et al
    Clinical characteristics, treatment, trajectories and outcome of patients with dilated cardiomyopathy in a national heart failure registry.
    Int J Cardiol. 2024 Mar 19:131986. doi: 10.1016/j.ijcard.2024.131986.
    PubMed     Abstract available


  51. KARAKITSOS P, Mylonas KS
    Raw data were not disclosed in 95% of PubMed-indexed heart failure meta-analyses in 2021: A systematic analysis of transparency.
    Int J Cardiol. 2024 Mar 19:131987. doi: 10.1016/j.ijcard.2024.131987.
    PubMed     Abstract available


  52. HUA L, Zhang R, Chen R, Shao W, et al
    A nomogram for predicting the risk of heart failure with preserved ejection fraction.
    Int J Cardiol. 2024 Mar 18:131973. doi: 10.1016/j.ijcard.2024.131973.
    PubMed     Abstract available


  53. LUND-ANDERSEN C, Yafasova A, Hofsten D, Thune JJ, et al
    Association between QRS shortening and mortality after cardiac resynchronization therapy: Results from the DANISH study.
    Int J Cardiol. 2024;399:131700.
    PubMed     Abstract available


  54. CHAO-CHEN L
    Letter to the Editor: "Changes in walking speed 6 months after discharge may be more sensitive to subsequent prognosis than handgrip strength in patients hospitalized for heart failure".
    Int J Cardiol. 2024 Mar 13:131958. doi: 10.1016/j.ijcard.2024.131958.
    PubMed    


  55. BACKHAUS SJ, Schulz A, Lange T, Schmidt-Schweda LS, et al
    Prognostic and diagnostic implications of impaired rest and exercise-stress left atrial compliance in heart failure with preserved ejection fraction: Insights from the HFpEF stress trial.
    Int J Cardiol. 2024 Mar 11:131949. doi: 10.1016/j.ijcard.2024.131949.
    PubMed     Abstract available


  56. BARSSOUM K, Abumoawad A, Chowdhury M, Agrawal A, et al
    Perioperative outcomes of hypertrophic cardiomyopathy: An insight from the National Readmission Database.
    Int J Cardiol. 2024;398:131601.
    PubMed     Abstract available


    February 2024
  57. KIKO T, Aoki T
    The relationship between duration of delirium and clinical outcomes in patients with acute heart failure.
    Int J Cardiol. 2024 Feb 23:131902. doi: 10.1016/j.ijcard.2024.131902.
    PubMed    


  58. LUO Z, Gong X, Liu Y, Hao K, et al
    Mitochondrial dysfunction due to miR-210/Drd5/ROS axis is a potential mechanism of heart failure.
    Int J Cardiol. 2024 Feb 20:131897. doi: 10.1016/j.ijcard.2024.131897.
    PubMed    


  59. GUAZZI M, Crisci G
    Exercise mean PAP to CO relationship: An insightful endpoint for testing therapeutic interventions in heart failure.
    Int J Cardiol. 2024 Feb 20:131899. doi: 10.1016/j.ijcard.2024.131899.
    PubMed    


  60. SIM DKL, Mittal S, Zhang J, Hung CL, et al
    Expert recommendations for the management of iron deficiency in patients with heart failure in Asia.
    Int J Cardiol. 2024 Feb 19:131890. doi: 10.1016/j.ijcard.2024.131890.
    PubMed     Abstract available


  61. LERMAN TT, Greenberg N, Fishman B, Goldman A, et al
    The real-world safety of sacubitril / valsartan among older adults (>/=75): A pharmacovigilance study from the FDA data.
    Int J Cardiol. 2024;397:131613.
    PubMed     Abstract available


  62. LV L, Chen Q, Lu J, Zhao Q, et al
    Potential regulatory role of epigenetic modifications in aging-related heart failure.
    Int J Cardiol. 2024 Feb 13:131858. doi: 10.1016/j.ijcard.2024.131858.
    PubMed     Abstract available


  63. ISMAIL TF
    Understanding heart failure and cardiomyopathy in Africa: Insights from cardiovascular magnetic resonance.
    Int J Cardiol. 2024 Feb 12:131847. doi: 10.1016/j.ijcard.2024.131847.
    PubMed    


  64. HAGE C, Lund LH
    Inflammation and myeloperoxidase - The next treatment targets in heart failure?
    Int J Cardiol. 2024 Feb 5:131834. doi: 10.1016/j.ijcard.2024.131834.
    PubMed    


  65. LI G, Liu X, Long A, Feng J, et al
    An inducible mouse model of heart failure targeted to cardiac Drd5 deficiency detonating mitochondrial oxidative stress.
    Int J Cardiol. 2024;396:131560.
    PubMed    


  66. IANNACCONE M, Barbero U, Franchin L, Montabone A, et al
    Comparison of mid-term mortality after surgical, supported or unsupported percutaneous revascularization in patients with severely reduced ejection fraction: A direct and network meta-analysis of adjusted observational studies and randomized-controlle
    Int J Cardiol. 2024;396:131428.
    PubMed     Abstract available


    January 2024
  67. FERREIRA JP, Claggett BL, Liu J, Sharma A, et al
    High-sensitivity C-reactive protein in heart failure with preserved ejection fraction: Findings from TOPCAT.
    Int J Cardiol. 2024 Jan 31:131818. doi: 10.1016/j.ijcard.2024.131818.
    PubMed     Abstract available


  68. XU L, Chen Y, Chen S, Wang G, et al
    Relationship between resting heart rate and long-term outcomes in stabilized patients with myocardial infarction: A prospective community-based cohort study.
    Int J Cardiol. 2024 Jan 24:131811. doi: 10.1016/j.ijcard.2024.131811.
    PubMed     Abstract available


  69. MIGLIORE F, Schiavone M, Pittorru R, Forleo GB, et al
    Left ventricular assist device in the presence of subcutaneous implantable cardioverter defibrillator: Data from a multicenter experience.
    Int J Cardiol. 2024 Jan 23:131807. doi: 10.1016/j.ijcard.2024.131807.
    PubMed     Abstract available


  70. YAMAGUCHI N, Hirata Y, Nishio S, Takahashi T, et al
    Pulmonary pressure-flow responses to exercise in heart failure treated with angiotensin receptor neprilysin inhibitor.
    Int J Cardiol. 2024 Jan 20:131789. doi: 10.1016/j.ijcard.2024.131789.
    PubMed     Abstract available


  71. MUSUMECI B, Tini G, Biagini E, Merlo M, et al
    Clinical characteristics and outcome of end stage hypertrophic cardiomyopathy: Role of age and heart failure phenotypes.
    Int J Cardiol. 2024 Jan 18:131784. doi: 10.1016/j.ijcard.2024.131784.
    PubMed     Abstract available


  72. KANG DW, Kang SH, Lee K, Nam K, et al
    Comparative efficacy of vericiguat to sacubitril/valsartan for patients with heart failure reduced ejection fraction: Systematic review and network meta-analysis.
    Int J Cardiol. 2024 Jan 17:131786. doi: 10.1016/j.ijcard.2024.131786.
    PubMed     Abstract available


  73. CHERBI M, Bouisset F, Bonnefoy E, Lamblin N, et al
    Characteristics, management, and mid-term prognosis of older adults with cardiogenic shock admitted to intensive care units: Insights from the FRENSHOCK registry.
    Int J Cardiol. 2024;395:131578.
    PubMed     Abstract available


  74. MUROKE V, Jalanko M, Haukka J, Anttila V, et al
    Long-term outcome after surgical correction of sinus venosus defect in a nationwide register-based cohort study.
    Int J Cardiol. 2024;395:131433.
    PubMed     Abstract available


  75. HANADA S, Adachi T, Iwatsu K, Kamisaka K, et al
    Changes in walking speed 6?months after discharge may be more sensitive to subsequent prognosis than handgrip strength in patients hospitalized for heart failure.
    Int J Cardiol. 2024 Jan 11:131778. doi: 10.1016/j.ijcard.2024.131778.
    PubMed     Abstract available


  76. QUATTRONE F, Aimo A, Zuccarino S, Morelli MS, et al
    Unmet needs in end-of-life care for heart failure patients.
    Int J Cardiol. 2024 Jan 10:131750. doi: 10.1016/j.ijcard.2024.131750.
    PubMed     Abstract available


  77. AIKAWA Y, Ogata S, Honda S, Nagai T, et al
    Prolonged delirium during hospitalization is associated with worse long-term and short-term outcomes in patients with acute heart failure.
    Int J Cardiol. 2024 Jan 10:131776. doi: 10.1016/j.ijcard.2024.131776.
    PubMed     Abstract available


  78. PASTORE MC, Vannuccini F, Mandoli GE, Lisi M, et al
    Myocardial work and left heart deformation parameters across primary mitral regurgitation severity.
    Int J Cardiol. 2024 Jan 9:131772. doi: 10.1016/j.ijcard.2024.131772.
    PubMed     Abstract available


  79. SRAYA R, Amsalem I, Carasso S, Gilad O, et al
    Mitral valve gradient changes associate with outcomes of patients undergoing transcatheter edge-to-edge repair.
    Int J Cardiol. 2024 Jan 9:131766. doi: 10.1016/j.ijcard.2024.131766.
    PubMed     Abstract available


  80. MIYOSHI T
    A novel genetically engineered mouse model for investigating heart failure mechanisms and therapeutic interventions.
    Int J Cardiol. 2024 Jan 3:131703. doi: 10.1016/j.ijcard.2023.131703.
    PubMed    


  81. EGBE AC, Abozied O, Miranda WR, Younis A, et al
    Prognostic role of inferior vena collapsibility index in congenital heart disease: A validation study.
    Int J Cardiol. 2024;394:131399.
    PubMed     Abstract available


    December 2023
  82. SAEED S, Bleie O
    Prognostic validation of first-phase ejection fraction in patients with heart failure: A new piece of evidence.
    Int J Cardiol. 2023 Dec 31:131692. doi: 10.1016/j.ijcard.2023.131692.
    PubMed    


  83. TAN Z, Liu Y, Hong K
    The association between serum chloride and mortality in ICU patients with heart failure: The impact of bicarbonate.
    Int J Cardiol. 2023 Dec 22:131672. doi: 10.1016/j.ijcard.2023.131672.
    PubMed     Abstract available


  84. ADAMO M, Pagnesi M, Di Pasquale M, Ravera A, et al
    Differential biomarker expression in heart failure patients with and without mitral regurgitation: Insights from BIOSTAT-CHF.
    Int J Cardiol. 2023 Dec 21:131664. doi: 10.1016/j.ijcard.2023.131664.
    PubMed     Abstract available


  85. WONG CN, Gui XY, Rabkin SW
    Myeloperoxidase, carnitine, and derivatives of reactive oxidative metabolites in heart failure with preserved versus reduced ejection fraction: A meta-analysis.
    Int J Cardiol. 2023 Dec 13:131657. doi: 10.1016/j.ijcard.2023.131657.
    PubMed     Abstract available


  86. OZLEK B
    Tricuspid regurgitation and heart failure with preserved ejection fraction: An enigma in cardiology practice.
    Int J Cardiol. 2023 Dec 10:131649. doi: 10.1016/j.ijcard.2023.131649.
    PubMed    


  87. HU H, Yang J
    Heart failure complicated by atrial fibrillation: How to make better choices for anticoagulation?
    Int J Cardiol. 2023 Dec 6:131644. doi: 10.1016/j.ijcard.2023.131644.
    PubMed    


  88. ELIA E, Bruno F, Crimi G, Wanha W, et al
    Gender differences in the development of heart failure after acute coronary syndrome: Insight from the CORALYS registry.
    Int J Cardiol. 2023 Dec 5:131622. doi: 10.1016/j.ijcard.2023.131622.
    PubMed     Abstract available


  89. GAO Y, Liu M, Ju Z, Wang H, et al
    Entropy as a novel predictor of cardiovascular events in patients with left ventricular noncompaction.
    Int J Cardiol. 2023;392:131279.
    PubMed     Abstract available


    November 2023
  90. JIN C, Chen G, Zhao C, Wu Y, et al
    First-phase ejection fraction to predict adverse outcomes in patients with heart failure.
    Int J Cardiol. 2023 Nov 30:131612. doi: 10.1016/j.ijcard.2023.131612.
    PubMed     Abstract available


  91. CHOI HM, Hwang IC, Choi HJ, Yoon YE, et al
    Irreversible myocardial injury attenuates the benefits of sacubitril/valsartan in heart failure patients.
    Int J Cardiol. 2023 Nov 27:131611. doi: 10.1016/j.ijcard.2023.131611.
    PubMed     Abstract available


  92. MORONI F, Corna G, Del Buono MG, Golino M, et al
    Impact of C-reactive protein levels and role of anakinra in patients with ST-elevation myocardial infarction.
    Int J Cardiol. 2023 Nov 26:131610. doi: 10.1016/j.ijcard.2023.131610.
    PubMed     Abstract available


  93. TAYAL B, Rorth R, Kristensen SL, Wissenberg M, et al
    Comparative outcomes in patients with preexisting heart failure to those without heart failure after out-of-hospital cardiac arrest: A nationwide registry study.
    Int J Cardiol. 2023 Nov 18:131595. doi: 10.1016/j.ijcard.2023.131595.
    PubMed     Abstract available


  94. ALEXANDRINO FB, Faaborg-Andersen CC, da Silva-de Abreu A
    Anticoagulation in patients with atrial fibrillation and heart failure: More than meets the eye?
    Int J Cardiol. 2023 Nov 16:131591. doi: 10.1016/j.ijcard.2023.131591.
    PubMed    


  95. LAU ATC, DiDomenico RJ, Kim K
    Cost-effectiveness of systematic screening and treatment of transthyretin amyloid cardiomyopathy (ATTR-CM) in patients with Heart failure with preserved ejection fraction (HFpEF) in United States.
    Int J Cardiol. 2023 Nov 16:131598. doi: 10.1016/j.ijcard.2023.131598.
    PubMed     Abstract available


  96. ROSSI VA, Laptseva N, Nebunu D, Haider T, et al
    Impaired retinal micro-vascular function in patients with atrial fibrillation.
    Int J Cardiol. 2023 Nov 16:131592. doi: 10.1016/j.ijcard.2023.131592.
    PubMed     Abstract available


  97. D'AMARIO D, Laborante R, Bianchini E, Galli M, et al
    Statins as preventive therapy for anthracycline cardiotoxicity: a meta-analysis of randomized controlled trials.
    Int J Cardiol. 2023;391:131219.
    PubMed     Abstract available


  98. CHAVALI S, Barua S, Adji A, Robson D, et al
    Safety and tolerability of sodium-glucose cotransporter-2 inhibitors in bridge-to-transplant patients supported with centrifugal-flow left ventricular assist devices.
    Int J Cardiol. 2023;391:131259.
    PubMed     Abstract available


  99. LI ZH, Zhong WF, Qiu CS, Yang P, et al
    Association between regular proton pump inhibitors use and cardiovascular outcomes: A large prospective cohort study.
    Int J Cardiol. 2023 Nov 5:131567. doi: 10.1016/j.ijcard.2023.131567.
    PubMed     Abstract available


  100. DORES H, Toste A, Cardim N
    Hypertrophic cardiomyopathy in patients with a normal electrocardiogram: A view from the east side of the Atlantic Ocean.
    Int J Cardiol. 2023;390:131260.
    PubMed     Abstract available


    October 2023
  101. MASE M, Rossi M, Setti M, Barbati G, et al
    Applicability and performance of heart failure prognostic scores in dilated cardiomyopathy: The real-world experience of an Italian referral center for cardiomyopathies.
    Int J Cardiol. 2023 Oct 29:131562. doi: 10.1016/j.ijcard.2023.131562.
    PubMed     Abstract available


  102. KOSEOGLU FD, Ozlek B
    Hemoglobin to red cell distribution width ratio in patients with heart failure with preserved ejection fraction.
    Int J Cardiol. 2023 Oct 27:131556. doi: 10.1016/j.ijcard.2023.131556.
    PubMed    


  103. SERAFIN A, Jasic-Szpak E, Marwick TH, Przewlocka-Kosmala M, et al
    Contribution of reduced skeletal muscle perfusion reserve to exercise intolerance in heart failure with preserved ejection fraction.
    Int J Cardiol. 2023 Oct 21:131553. doi: 10.1016/j.ijcard.2023.131553.
    PubMed     Abstract available


  104. SERI A, Rabadi A, Baral N, Andi K, et al
    Prevalence of respiratory failure and use of mechanical ventilation in heart failure patients undergoing left atrial appendage occlusion device implantation.
    Int J Cardiol. 2023 Oct 21:131552. doi: 10.1016/j.ijcard.2023.131552.
    PubMed     Abstract available


  105. ZITO A, Restivo A, D'Amario D
    Reply to "Comment on: Heart failure management guided by remote multiparameter monitoring: A meta-analysis".
    Int J Cardiol. 2023 Oct 20:131545. doi: 10.1016/j.ijcard.2023.131545.
    PubMed    


  106. ANSARI RAMANDI MM, Yarmohammadi H, Gareb B, Voors AA, et al
    Long-term outcome of patients with transposition of the great arteries and a systemic right ventricle: A systematic review and meta-analysis.
    Int J Cardiol. 2023;389:131159.
    PubMed     Abstract available


  107. JAIN SS, Yu J, Arnott C, Neal B, et al
    Treatment effect of canagliflozin for patients on therapy for heart failure: Pooled analysis of the CANVAS program and CREDENCE trial.
    Int J Cardiol. 2023 Oct 14:131444. doi: 10.1016/j.ijcard.2023.131444.
    PubMed     Abstract available


  108. IMANISHI J, Iwasaki M, Ujiro S, Nakano T, et al
    Accuracy of lung ultrasound examinations of residual congestion performed by novice residents in patients with acute heart failure.
    Int J Cardiol. 2023 Oct 14:131446. doi: 10.1016/j.ijcard.2023.131446.
    PubMed     Abstract available


  109. LEONARDI D, Bursi F, Fanti D, Dotto A, et al
    Outpatient tricuspid regurgitation in the community: Clinical context and outcome.
    Int J Cardiol. 2023 Oct 14:131443. doi: 10.1016/j.ijcard.2023.131443.
    PubMed     Abstract available


  110. MOCKEL M, Pudasaini S, Baberg HT, Levenson B, et al
    Oral anticoagulation in heart failure complicated by atrial fibrillation: A nationwide routine data study.
    Int J Cardiol. 2023 Oct 10:131434. doi: 10.1016/j.ijcard.2023.131434.
    PubMed     Abstract available


  111. ROONGSANGMANOON W, Wongsoasup A, Chichareon P, Suwannasom P, et al
    Validation of the academic research consortium high bleeding risk definition in Thai PCI registry.
    Int J Cardiol. 2023;388:131167.
    PubMed     Abstract available


    September 2023
  112. ZHENG H, Yin Z, Luo X, Zhou Y, et al
    Associations between systemic immunity-inflammation index and heart failure: Evidence from the NHANES 1999-2018.
    Int J Cardiol. 2023 Sep 26:131400. doi: 10.1016/j.ijcard.2023.131400.
    PubMed     Abstract available


  113. FONDERICO C, Pergola V, Faccenda D, Salucci A, et al
    Impact of sacubitril/valsartan and gliflozins on cardiac resynchronization therapy response in ischemic and non-ischemic heart failure patients.
    Int J Cardiol. 2023 Sep 23:131391. doi: 10.1016/j.ijcard.2023.131391.
    PubMed     Abstract available


  114. BAUMHOVE L, Bomer N, Tromp J, van Essen BJ, et al
    Clinical characteristics and prognosis of patients with heart failure and high concentrations of interleukin-17D.
    Int J Cardiol. 2023 Sep 21:131384. doi: 10.1016/j.ijcard.2023.131384.
    PubMed     Abstract available


  115. CHEN H, Zhen Z, Dong Y, Liu C, et al
    Hemoglobin to red cell distribution width ratio: A predictor of clinical outcome and diuretic response in patients with acute heart failure.
    Int J Cardiol. 2023 Sep 20:131368. doi: 10.1016/j.ijcard.2023.131368.
    PubMed     Abstract available


  116. LI T, Li Z, Guo S, Jiang S, et al
    The value of using left ventricular pressure-strain loops to evaluate myocardial work in predicting heart failure with improved ejection fraction.
    Int J Cardiol. 2023 Sep 19:131366. doi: 10.1016/j.ijcard.2023.131366.
    PubMed     Abstract available


  117. ANDI K, Abozied O, Miranda WR, Anderson JH, et al
    Clinical benefits of angiotensin receptor-Neprilysin inhibitor in adults with congenital heart disease.
    Int J Cardiol. 2023;387:131152.
    PubMed     Abstract available


  118. TSABEDZE N, Mpanya D, Bailly C, Nel S, et al
    Clinical characteristics and one-year all-cause mortality outcomes in Africans with dilated cardiomyopathy.
    Int J Cardiol. 2023;387:131142.
    PubMed     Abstract available


  119. LEE YH, Kim SM, Kim EK, Park SJ, et al
    Pattern of pericardial calcification determines mid-term postoperative outcomes after pericardiectomy in chronic constrictive pericarditis.
    Int J Cardiol. 2023;387:131133.
    PubMed     Abstract available


  120. ZHANG TY, An DA, Zhou H, Ni Z, et al
    Fractal analysis: Left ventricular trabecular complexity cardiac MRI adds independent risks for heart failure with preserved ejection fraction in participants with end-stage renal disease.
    Int J Cardiol. 2023 Sep 9:131334. doi: 10.1016/j.ijcard.2023.131334.
    PubMed     Abstract available


  121. LEE K, Jung JH, Kwon W, Ohn C, et al
    The prognostic value of cardiopulmonary exercise testing and HFA-PEFF in patients with unexplained dyspnea and preserved left ventricular ejection fraction.
    Int J Cardiol. 2023;386:74-82.
    PubMed     Abstract available


    August 2023
  122. KHAZAEI S, Jenabi E
    Comment on: Heart failure management guided by remote multiparameter monitoring: A meta-analysis.
    Int J Cardiol. 2023 Aug 22:131281. doi: 10.1016/j.ijcard.2023.131281.
    PubMed    


  123. PUST F, Deis T, Larsson J, Hansen BL, et al
    Importance of heart failure duration for development of pulmonary hypertension in advanced heart failure.
    Int J Cardiol. 2023 Aug 19:131232. doi: 10.1016/j.ijcard.2023.131232.
    PubMed     Abstract available


  124. CHO Y, Ueda T, Kotani S, Okada K, et al
    AATS 2023: Left ventricular restoration with scar exclusion in the surgical treatment for ischemic heart failure.
    Int J Cardiol. 2023 Aug 18:131277. doi: 10.1016/j.ijcard.2023.131277.
    PubMed     Abstract available


  125. DOGAR ME, Azeem B, Asim R
    Comment on SGLT-2 inhibitors for treatment of heart failure in patients with and without type 2 diabetes: A practical approach for routine clinical practice.
    Int J Cardiol. 2023 Aug 9:131255. doi: 10.1016/j.ijcard.2023.131255.
    PubMed    


  126. LO JJ, Tromp J, Ouwerkwerk W, Ong MEH, et al
    Examining predictors for 6-month mortality and healthcare utilization for patients admitted for heart failure in the acute care setting.
    Int J Cardiol. 2023 Aug 1:131237. doi: 10.1016/j.ijcard.2023.131237.
    PubMed     Abstract available


    July 2023
  127. SANCHIS L, Farrero M
    Edge to edge mitral valve repair beyond COAPT criteria: A bridge to further therapies for patients with advanced heart failure.
    Int J Cardiol. 2023 Jul 31:131235. doi: 10.1016/j.ijcard.2023.131235.
    PubMed    


  128. DE CLERCQ L, Er A, Handoko ML, van Weert HCPM, et al
    Characteristics of heart failure in the Amsterdam metropolitan area (AMSTERDAM-HF): Data from a dynamic general practice cohort (2011-2021).
    Int J Cardiol. 2023 Jul 25:131217. doi: 10.1016/j.ijcard.2023.131217.
    PubMed     Abstract available


  129. TAVERAS HIRALDO A, Canahuate Rodriguez G
    Predicting heart failure rollback.
    Int J Cardiol. 2023 Jul 20:131197. doi: 10.1016/j.ijcard.2023.131197.
    PubMed    


  130. JONG CB, Lu TS, Chen TY, Chen CK, et al
    Subclinical myocardial injury increases the risk of heart failure in patients with and without type 2 diabetes post-acute coronary syndrome.
    Int J Cardiol. 2023 Jul 18:131195. doi: 10.1016/j.ijcard.2023.131195.
    PubMed     Abstract available


  131. PAVLOV M, Vidak M
    Safety of benzodiazepines in patients with acute heart failure: Questions to be answered.
    Int J Cardiol. 2023 Jul 14:131191. doi: 10.1016/j.ijcard.2023.131191.
    PubMed    


  132. ICHIHARA YK, Shiraishi Y, Kohsaka S, Nakano S, et al
    Association of pre-hospital precipitating factors with short- and long-term outcomes of acute heart failure patients: A report from the WET-HF2 registry.
    Int J Cardiol. 2023 Jul 10:131161. doi: 10.1016/j.ijcard.2023.131161.
    PubMed     Abstract available


  133. ZITO A, Restivo A, Ciliberti G, Laborante R, et al
    Heart failure management guided by remote multiparameter monitoring: A meta-analysis.
    Int J Cardiol. 2023 Jul 8:131163. doi: 10.1016/j.ijcard.2023.131163.
    PubMed     Abstract available


  134. SUN Y, Wang C, Ren J
    CRT upgrading might be a potential therapy in pacemaker-induced cardiomyopathy.
    Int J Cardiol. 2023;382:62.
    PubMed    


  135. WANG RJ, Xu C, Tang HF
    A cardiovascular polypharmacy perspective on octogenarians with HFpEF.
    Int J Cardiol. 2023;382:60-61.
    PubMed    


    June 2023
  136. CASTIGLIONE V, Gentile F, Vergaro G
    Cachexia, sarcopenia and heart failure: A last mile to be walked.
    Int J Cardiol. 2023 Jun 24:131131. doi: 10.1016/j.ijcard.2023.131131.
    PubMed    


  137. MORITA K, Miyamoto Y, Mizuno A, Shirane S, et al
    Impact of a financial incentive scheme for team-based palliative care in patients with heart failure in Japan: A nationwide database study.
    Int J Cardiol. 2023 Jun 24:131145. doi: 10.1016/j.ijcard.2023.131145.
    PubMed     Abstract available


  138. MARGONATO D, Ancona F, Cesari A, Ghantous E, et al
    The long-term clinical course of moderate tricuspid regurgitation.
    Int J Cardiol. 2023 Jun 24:131135. doi: 10.1016/j.ijcard.2023.131135.
    PubMed     Abstract available


  139. MUNAFO AR, Scotti A, Estevez-Loureiro R, Adamo M, et al
    2-year outcomes of MitraClip as a bridge to heart transplantation: The international MitraBridge registry.
    Int J Cardiol. 2023 Jun 22:131139. doi: 10.1016/j.ijcard.2023.131139.
    PubMed     Abstract available


  140. GALATI G, Germanova O, Pedretti RFE, Ambrosio G, et al
    Hypotension and optimization of heart failure therapy after a recent hospitalization for heart failure: When the going gets tough, the tough get going.
    Int J Cardiol. 2023 Jun 13:131118. doi: 10.1016/j.ijcard.2023.131118.
    PubMed    


  141. CAMILLI M, Iannaccone G, Russo M, Meucci MC, et al
    Early improvement of strain imaging parameters predicts long-term response to sacubitril/valsartan in patients with heart failure with reduced ejection fraction: An observational prospective study.
    Int J Cardiol. 2023 Jun 6:S0167-5273(23)00835.
    PubMed     Abstract available


    May 2023
  142. ZHANG X, Lv X, Wang N, Yu S, et al
    WATCH-DM risk score predicts the prognosis of diabetic phenotype patients with heart failure and preserved ejection fraction.
    Int J Cardiol. 2023 May 29:S0167-5273(23)00738.
    PubMed     Abstract available


  143. MUTOLI M, Martelli F, Spinetti G
    TfR1 gene expression as a potential biomarker for iron deficiency in heart failure.
    Int J Cardiol. 2023 May 23:S0167-5273(23)00722.
    PubMed    


  144. WU L, Wu M, Zhang X, Chen S, et al
    Increased arterial stiffness elevates the risk of heart failure in diabetic patients.
    Int J Cardiol. 2023 May 23:S0167-5273(23)00732.
    PubMed     Abstract available


  145. ANGELICO-GONCALVES A, Leite AR, Neves JS, Saraiva F, et al
    Changes in health-related quality of life and treatment effects in chronic heart failure: A meta-analysis.
    Int J Cardiol. 2023 May 19:S0167-5273(23)00726.
    PubMed     Abstract available


  146. MEIJS C, Brugts JJ, Lund LH, Linssen GCM, et al
    Identifying distinct clinical clusters in heart failure with mildly reduced ejection fraction.
    Int J Cardiol. 2023 May 16:S0167-5273(23)00718.
    PubMed     Abstract available


  147. CABRERA C, Frisk C, Lofstrom U, Lynga P, et al
    Relationship between iron deficiency and expression of genes involved in iron metabolism in human myocardium and skeletal muscle.
    Int J Cardiol. 2023;379:82-88.
    PubMed     Abstract available


  148. KUCHTARUK AA, Sparrow RT, Azzalini L, Garcia S, et al
    Unplanned readmissions after Impella mechanical circulatory support.
    Int J Cardiol. 2023;379:48-59.
    PubMed     Abstract available


  149. ALHAKAK AS, Olsen FJ, Skaarup KG, Lassen MCH, et al
    Changes in cardiac time intervals over a decade and the risk of incident heart failure: The Copenhagen City heart study.
    Int J Cardiol. 2023 May 11:S0167-5273(23)00709.
    PubMed     Abstract available


  150. MELENDO-VIU M, Dobarro D, Lopez AM, Dominguez LM, et al
    Hypotension at heart failure discharge: Should it be a limiting factor for drug titration?
    Int J Cardiol. 2023 May 9:S0167-5273(23)00658.
    PubMed     Abstract available


  151. MAGRI D, Palermo P, Salvioni E, Mapelli M, et al
    Influence of exertional oscillatory breathing and its temporal behavior in patients with heart failure and reduced ejection fraction.
    Int J Cardiol. 2023 May 8:S0167-5273(23)00659.
    PubMed     Abstract available


  152. FRANCESCO A, Davide M, Gregorio M, Matteo B, et al
    Ratio between right ventricular longitudinal strain and pulmonary arterial systolic pressure: A novel prognostic parameter in patients with severe tricuspid regurgitation.
    Int J Cardiol. 2023 May 4:S0167-5273(23)00647.
    PubMed     Abstract available


  153. KOH SJQ, Yap J, Jiang Y, Sng GGR, et al
    Clinical outcomes in end stage renal disease on dialysis and severe coronary artery disease: A real-world study.
    Int J Cardiol. 2023;378:105-110.
    PubMed     Abstract available


    April 2023
  154. ASAUMI Y
    Peripheral vein pressure as a less-invasive marker at the vulnerable phase after hospitalization of heart failure.
    Int J Cardiol. 2023 Apr 28:S0167-5273(23)00593.
    PubMed    


  155. BOTTIROLI M, Calini A, Morici N, Tavazzi G, et al
    Acute kidney injury in patients with acute decompensated heart failure-cardiogenic shock: Prevalence, risk factors and outcome.
    Int J Cardiol. 2023 Apr 28:S0167-5273(23)00612.
    PubMed     Abstract available


  156. ZEITOUNI M, Morlon Q, Silvain J, Procopi N, et al
    Implication of the new definition of pulmonary hypertension in patients evaluated for heart transplantation.
    Int J Cardiol. 2023 Apr 27:S0167-5273(23)00602.
    PubMed     Abstract available


  157. SINGAM NSV, Tabi M, Wiley B, Anavekar N, et al
    Echocardiographic findings in cardiogenic shock due to acute myocardial infarction versus heart failure.
    Int J Cardiol. 2023 Apr 26:S0167-5273(23)00595.
    PubMed     Abstract available


  158. NISHINO M, Egami Y, Yamada T, Yasumura Y, et al
    Reply to "Prognostic impact of cardiovascular polypharmacy on octogenarians with heart failure with preserved ejection fraction".
    Int J Cardiol. 2023 Apr 17:S0167-5273(23)00536.
    PubMed    


  159. FERREIRA JP, Cleland JG, Girerd N, Rossignol P, et al
    Spironolactone effect on circulating procollagen type I carboxy-terminal propeptide: Pooled analysis of three randomized trials.
    Int J Cardiol. 2023;377:86-88.
    PubMed     Abstract available


  160. CHRISTOPH M, Marius S, Karl S, Friedrich K, et al
    Efficacy of CRT upgrade in pacemaker-induced cardiomyopathy in an outpatient clinic - Results of a prospective registry.
    Int J Cardiol. 2023;377:60-65.
    PubMed     Abstract available


  161. YANG Q, Wu H, Liu D, Li Y, et al
    Discussion of a study on the role of EMS in prognosis of elderly patients with AHF.
    Int J Cardiol. 2023;377:91.
    PubMed    


  162. SALAMANCA-BAUTISTA P, Romero-Correa M, Formiga F, Antequera-Martin-Portugues I, et al
    Safety of benzodiazepines in patients with acute heart failure: A propensity score-matching study.
    Int J Cardiol. 2023 Apr 14:S0167-5273(23)00529.
    PubMed     Abstract available


  163. EDER M, Griffin M, Moreno-Villagomez J, Bellumkonda L, et al
    The importance of forward flow and venous congestion in diuretic response in acute heart failure: Insights from the ESCAPE trial.
    Int J Cardiol. 2023 Apr 4:S0167-5273(23)00517.
    PubMed     Abstract available


    March 2023
  164. LUO Q, Zhuang B, Li G, Jiang Y, et al
    Consistency evaluation of exercise target heart rate determined by resting heart rate and anaerobic threshold in chronic heart failure patients.
    Int J Cardiol. 2023 Mar 29:S0167-5273(23)00467.
    PubMed     Abstract available


  165. HORTEGAL RA, Valeri R, Grizante M, Cancellier R, et al
    Afterload increase challenge unmasks systolic abnormalities in heart failure with preserved ejection fraction.
    Int J Cardiol. 2023 Mar 21:S0167-5273(23)00453.
    PubMed     Abstract available


  166. FUJIMOTO Y, Maeda D, Kagiyama N, Sunayama T, et al
    Prevalence and prognostic impact of the coexistence of cachexia and sarcopenia in older patients with heart failure.
    Int J Cardiol. 2023 Mar 17:S0167-5273(23)00447.
    PubMed     Abstract available


  167. TAKIMURA H, Taniguchi R, Tsuzuki I, Tajima E, et al
    Impact of the time-to-target rate of urine volume concept on the outcome of acute decompensated heart failure.
    Int J Cardiol. 2023 Mar 17:S0167-5273(23)00445.
    PubMed     Abstract available


  168. KUMAR HU, Nearing BD, Mittal S, Premchand RK, et al
    Autonomic regulation therapy in chronic heart failure with preserved/mildly reduced ejection fraction: ANTHEM-HFpEF study results.
    Int J Cardiol. 2023 Mar 17:S0167-5273(23)00440.
    PubMed     Abstract available


  169. ZHANG HD, Yan Y, He YY, Liu QQ, et al
    Characteristics of exercise intolerance in different subgroups of pulmonary arterial hypertension associated with congenital heart disease.
    Int J Cardiol. 2023;375:29-35.
    PubMed     Abstract available


  170. LI X, Shen Y, Xu X, Guo G, et al
    Genomic and RNA-Seq profiling of patients with HFrEF unraveled OAS1 mutation and aggressive expression.
    Int J Cardiol. 2023;375:44-54.
    PubMed     Abstract available


  171. FUJIMOTO Y, Maeda D, Kagiyama N, Sunayama T, et al
    Prognostic implications of six-minute walking distance in patients with heart failure with preserved ejection fraction.
    Int J Cardiol. 2023 Mar 11:S0167-5273(23)00396.
    PubMed     Abstract available


  172. BURGER PM, Koudstaal S, Dorresteijn JAN, Savarese G, et al
    Metabolic syndrome and risk of incident heart failure in non-diabetic patients with established cardiovascular disease.
    Int J Cardiol. 2023 Mar 11:S0167-5273(23)00395.
    PubMed     Abstract available


  173. HEEGAARD B, Deis T, Rossing K, Ersboll M, et al
    Diabetes mellitus and hemodynamics in advanced heart failure.
    Int J Cardiol. 2023 Mar 10:S0167-5273(23)00341.
    PubMed     Abstract available


  174. KAWAJI T, Shiomi H, Bao B, Hojo S, et al
    Intracardiac energy inefficiency during atrial fibrillation rhythm with heart failure: Assessment by echo-vector flow mapping.
    Int J Cardiol. 2023 Mar 10:S0167-5273(23)00392.
    PubMed     Abstract available


  175. DURAN A, Ventura HO
    The value of frequent objective risk assessments in heart failure management.
    Int J Cardiol. 2023 Mar 6:S0167-5273(23)00333.
    PubMed    


  176. MOHEBI R, Liu Y, Murphy SP, Gaggin HK, et al
    Clinical profiling of end-stage heart failure with preserved ejection fraction: The National Readmission Database.
    Int J Cardiol. 2023 Mar 2:S0167-5273(23)00269.
    PubMed     Abstract available


  177. ZAMPIERI M, Salvi S, Fumagalli C, Argiro A, et al
    Clinical scenarios of hypertrophic cardiomyopathy-related mortality: Relevance of age and stage of disease at presentation.
    Int J Cardiol. 2023;374:65-72.
    PubMed     Abstract available


  178. LIU Y, Li Y, Zhang J, Zhao Y, et al
    Pregnancy outcomes of women with Eisenmenger syndrome: A single-center study.
    Int J Cardiol. 2023;374:35-41.
    PubMed     Abstract available


    February 2023
  179. DIEZ MPL, Alquezar-Arbe A, Jacob J, Llorens P, et al
    Hospital development of heart failure follow-up units and short-term prognosis after acute decompensation in Spain.
    Int J Cardiol. 2023 Feb 17:S0167-5273(23)00247.
    PubMed     Abstract available


  180. SEFEROVIC PM, Polovina M, Seferovic J, Rosano G, et al
    Corrigendum to "Strength in synergy: Cardiometabolic effects of sacubitril/valsartan in heart failure and diabetes" [International Journal of Cardiology 2023 Jan 15;371:293-294 10.1016/j.ijcard.2022.09.019.
    Int J Cardiol. 2023 Feb 16:S0167-5273(23)00232.
    PubMed    


  181. XING C, Wang X, Pan X, Yu J, et al
    Outcomes of atrial septostomy and effect on long-term survival in patients with idiopathic pulmonary arterial hypertension: A single-center cohort.
    Int J Cardiol. 2023;373:118-123.
    PubMed     Abstract available


  182. SHIROTANI S, Jujo K, Takada T, Abe T, et al
    Renin-angiotensin system inhibitor exerts prognostic effects in HFpEF patients with low baseline chloride level.
    Int J Cardiol. 2023;373:83-89.
    PubMed     Abstract available


  183. NISHINO M, Egami Y, Kawanami S, Sugae H, et al
    Prognostic impact of cardiovascular polypharmacy on octogenarians with heart failure with preserved ejection fraction.
    Int J Cardiol. 2023 Feb 14:S0167-5273(23)00237.
    PubMed     Abstract available


  184. KERSTENS TP, Weerts J, van Dijk APJ, Weijers G, et al
    Left ventricular strain-volume loops and diastolic dysfunction in suspected heart failure with preserved ejection fraction.
    Int J Cardiol. 2023 Feb 14:S0167-5273(23)00167.
    PubMed     Abstract available


  185. YANAGISAWA S, Inden Y, Murohara T
    Catheter ablation for atrial fibrillation in heart failure: Getting closer to the full picture in the whole population.
    Int J Cardiol. 2023 Feb 13:S0167-5273(23)00226.
    PubMed    


  186. GOES-SANTOS BR, Rondon E, Fonseca GWP, Sales ARK, et al
    Physical capacity increase in patients with heart failure is associated with improvement in muscle sympathetic nerve activity.
    Int J Cardiol. 2023 Feb 13:S0167-5273(23)00234.
    PubMed     Abstract available


  187. CAMPBELL-QUINTERO S, Echeverria LE, Gomez-Mesa JE, Rivera-Toquica A, et al
    Comorbidity profile and outcomes in patients with chronic heart failure in a Latin American country: Insights from the Colombian heart failure registry (RECOLFACA).
    Int J Cardiol. 2023 Feb 13:S0167-5273(23)00236.
    PubMed     Abstract available


  188. KOSTANJSEK L, Ardissino M, Moussa O, Rayes B, et al
    Effect of bariatric surgery on the incidence of heart failure: A propensity score matched nationwide cohort study.
    Int J Cardiol. 2023 Feb 2:S0167-5273(23)00169.
    PubMed     Abstract available


    January 2023
  189. NGUYEN BN, Mital S, Bugden S, Nguyen HV, et al
    Cost-effectiveness of dapagliflozin and empagliflozin for treatment of heart failure with reduced ejection fraction.
    Int J Cardiol. 2023 Jan 31:S0167-5273(23)00120.
    PubMed     Abstract available


  190. PEZZUTO B, Piepoli M, Galotta A, Sciomer S, et al
    The importance of re-evaluating the risk score in heart failure patients: An analysis from the Metabolic Exercise Cardiac Kidney Indexes (MECKI) score database.
    Int J Cardiol. 2023 Jan 27:S0167-5273(23)00110.
    PubMed     Abstract available


  191. WERNHART S, Papathanasiou M, Rassaf T, Luedike P, et al
    Heart failure classification based on resting ejection fraction does not display a unique exercise response pattern.
    Int J Cardiol. 2023 Jan 27:S0167-5273(23)00113.
    PubMed     Abstract available


  192. CASULA M, Pignalosa L, Quilico F, Scajola LV, et al
    A comprehensive meta-analysis comparing radiofrequency ablation versus pharmacological therapy for the treatment of atrial fibrillation in patients with heart failure.
    Int J Cardiol. 2023 Jan 26:S0167-5273(23)00111.
    PubMed     Abstract available


  193. CANEPA M, Leporatti L, Persico L, Ameri P, et al
    Corrigendum to "Frequency, characteristics and prognostic impact of hospital readmissions in elderly patients with heart failure: A population study from 2013 to 2017 in Liguria, Northern Italy" [Int J Cardiol. 2022 Sep 15;363:111-118].
    Int J Cardiol. 2023 Jan 20:S0167-5273(23)00057.
    PubMed    


  194. KONG G, Chin YH, Chong B, Goh RSJ, et al
    Higher mortality in acute coronary syndrome patients without standard modifiable risk factors: Results from a global meta-analysis of 1,285,722 patients.
    Int J Cardiol. 2023;371:432-440.
    PubMed     Abstract available


  195. KIRSCH M, Feriel M, Aurelia LT, Oksana K, et al
    Impact of training on combined cardiopulmonary exercise test with stress echocardiography parameters in HFrEF patients.
    Int J Cardiol. 2023;371:252-258.
    PubMed     Abstract available


  196. TOTO F, Salvioni E, Magri D, Sciomer S, et al
    Does moderate hyperkalemia influence survival in HF? Insights from the MECKI score data base.
    Int J Cardiol. 2023;371:273-277.
    PubMed     Abstract available


  197. LIANG J, Zhang Z
    Predictors of in-hospital heart failure in patients with acute anterior wall ST-segment elevation myocardial infarction.
    Int J Cardiol. 2023 Jan 10:S0167-5273(23)00043.
    PubMed     Abstract available


  198. MIYAMOTO R, Nagao K, Matsuto K, Hata R, et al
    Relationship between atrial fibrillation and a liver fibrogenesis marker in patients with acute heart failure.
    Int J Cardiol. 2023 Jan 10:S0167-5273(23)00001.
    PubMed     Abstract available


  199. IWAHASHI N
    Right ventricular strain and mechanical dispersion for heart failure with preserved ejection fraction.
    Int J Cardiol. 2023 Jan 5:S0167-5273(22)01977.
    PubMed    


  200. MATSUTO K, Maruichi-Kawakami S, Aida K, Imamoto K, et al
    Prognostic implications of post-discharge hemodynamic congestion assessed by peripheral venous pressure among patients discharged from acute heart failure.
    Int J Cardiol. 2023 Jan 4:S0167-5273(22)01982.
    PubMed     Abstract available


  201. GALASSI A, Cara A, Magagnoli L, Faccioli FM, et al
    Do SGLT2 inhibitors protect elderly patients from HF rehospitalization and CKD progression? More opportunities than concerns.
    Int J Cardiol. 2023;370:321-322.
    PubMed    


  202. TROMBARA F, Alimento ML
    Should we be afraid of moderate hyperkalemia in HFrEF outpatients?
    Int J Cardiol. 2023;370:323-324.
    PubMed    


  203. ZANNONI J, Guazzi M, Milani V, Bandera F, et al
    Prognostic value of cardiopulmonary exercise testing in a European cohort with cardiovascular risk factors absent of a cardiovascular disease diagnosis.
    Int J Cardiol. 2023;370:402-404.
    PubMed     Abstract available


  204. LUND LH, Zeymer U, Clark AL, Barrios V, et al
    Association between sacubitril/valsartan initiation and changes in left ventricular ejection fraction: Insights from ARIADNE registry.
    Int J Cardiol. 2023;370:279-286.
    PubMed     Abstract available


    December 2022
  205. KOBAYASHI M, Ferreira JP, Matsue Y, Chikamori T, et al
    Effect of eplerenone on clinical stability of Japanese patients with acute heart failure.
    Int J Cardiol. 2022 Dec 28:S0167-5273(22)01938.
    PubMed     Abstract available


  206. KURASHIMA S, Kitai T, Matsue Y, Nogi K, et al
    Trajectory of serum chloride levels during decongestive therapy in acute heart failure.
    Int J Cardiol. 2022 Dec 27:S0167-5273(22)01933.
    PubMed     Abstract available


  207. AMPARO TAVERAS H
    The dilemma of thromboembolism prophylaxis in patient with acute heart failure.
    Int J Cardiol. 2022 Dec 16:S0167-5273(22)01913.
    PubMed    


  208. JUG B
    Heart failure with reduced ejection fraction and low blood pressure: Overcoming another barrier to guideline-directed medical therapy?
    Int J Cardiol. 2022 Dec 8:S0167-5273(22)01882.
    PubMed    


  209. KAUR G, Jones M, Howes L, Hattingh HL, et al
    Systematic review and meta-analysis of the association between all-cause mortality and statin therapy in patients with preserved ejection fraction heart failure (HFpEF).
    Int J Cardiol. 2022 Dec 7:S0167-5273(22)01871.
    PubMed     Abstract available


  210. WEWER ALBRECHTSEN NJ, Bojsen-Moller KN
    Letter to the Editor regarding to 'Activation of GLP-1 receptor signalling by sacubitril/valsartan: Implications for patients with poor glycaemic control'.
    Int J Cardiol. 2022;368:55.
    PubMed    


    November 2022
  211. SEPHIEN A, Ghobrial M, Reljic T, Prida X, et al
    Efficacy of SGLT2 inhibitors in patients with heart failure: An overview of systematic reviews.
    Int J Cardiol. 2022 Nov 28:S0167-5273(22)01739.
    PubMed     Abstract available


  212. VAN BERGEIJK KH, Wykrzykowska JJ, Sartori S, Snyder C, et al
    Pre-procedural oral anticoagulant use is associated with cardiovascular events in women after transcatheter aortic valve replacement: An analysis from the WIN-TAVI cohort.
    Int J Cardiol. 2022 Nov 28:S0167-5273(22)01743.
    PubMed     Abstract available


  213. KANG Y, Hwang HY
    Carbohydrate antigen 125; A biomarker not only for medical patients but also for surgical patients with heart failure.
    Int J Cardiol. 2022 Nov 26:S0167-5273(22)01733.
    PubMed    


  214. DU Y, Yuan N, Yan J, Han G, et al
    Identification of echocardiographic subgroups in patients with coronary heart disease combined with heart failure based on latent variable stratification.
    Int J Cardiol. 2022 Nov 25:S0167-5273(22)01725.
    PubMed     Abstract available


  215. MAHTANI K, Patel B, Wang B, Barron A, et al
    Activation of GLP-1 receptor signalling by sacubitril/valsartan: Implications for patients with poor glycaemic control.
    Int J Cardiol. 2022;367:81-89.
    PubMed     Abstract available


  216. HAMATANI Y, Kato T, Morimoto T, Iguchi M, et al
    Association of intravenous heparin administration with in-hospital clinical outcomes among hospitalized patients with acute heart failure.
    Int J Cardiol. 2022 Nov 11. pii: S0167-5273(22)01705.
    PubMed     Abstract available


  217. CAI J, Zhang L, Chen C, Ge J, et al
    Association between serum klotho concentration and heart failure in adults, a cross-sectional study from NHANES 2007-2016.
    Int J Cardiol. 2022 Nov 6. pii: S0167-5273(22)01697.
    PubMed     Abstract available


  218. PASQUALIN G, Chessa M
    HFpEF, HFmEF, HFrEF in adults with congenital heart disease: Time to face it.
    Int J Cardiol. 2022;366:19.
    PubMed    


  219. GOMEZ-HOSPITAL JA, Ferreiro JL
    Percutaneous circulatory support in high-risk PCI: Pulsatile or continuous flow devices?
    Int J Cardiol. 2022;366:80-81.
    PubMed    


    October 2022
  220. SHANAH L, Mir T, Uddin MM, Hussain T, et al
    Clinical outcomes and 30-day readmissions for heart failure with reduced ejection fraction with cardiorenal syndrome: A National Cohort Study.
    Int J Cardiol. 2022 Oct 31. pii: S0167-5273(22)01672.
    PubMed     Abstract available


  221. DE FILIPPO O, D'Ascenzo F, Wojciech W, Leonardi S, et al
    IncidenCe and predictOrs of heaRt fAiLure after acute coronarY Syndrome: The CORALYS registry.
    Int J Cardiol. 2022 Oct 25. pii: S0167-5273(22)01658.
    PubMed     Abstract available


  222. FAABORG-ANDERSEN CC, daSilva-deAbreu A, Ventura HO
    Optimized dosing of guideline-directed medical therapies is essential in heart failure with reduced ejection fraction.
    Int J Cardiol. 2022 Oct 20. pii: S0167-5273(22)01648.
    PubMed    


  223. BEREZIN AE
    Heart failure with recovered ejection fraction: The role of HbA1c level in hospitalized heart failure patients with type 2 diabetes.
    Int J Cardiol. 2022 Oct 19. pii: S0167-5273(22)01531.
    PubMed    


  224. KANEKO T, Kagiyama N, Nakamura Y, Dotare T, et al
    External validation of the ACUTE HF score for risk stratification in acute heart failure.
    Int J Cardiol. 2022 Oct 18. pii: S0167-5273(22)01641.
    PubMed     Abstract available


  225. KISHIHARA M, Takada T, Jujo K, Shirotani S, et al
    Prognostic impact of guideline-directed medical therapy in patients with heart failure on regular hemodialysis.
    Int J Cardiol. 2022 Oct 18. pii: S0167-5273(22)01642.
    PubMed     Abstract available


  226. IZUMI K, Kohno T, Goda A, Takeuchi S, et al
    Low blood pressure and guideline-directed medical therapy in patients with heart failure with reduced ejection fraction.
    Int J Cardiol. 2022 Oct 18. pii: S0167-5273(22)01640.
    PubMed     Abstract available


  227. TAKEUCHI S, Kohno T, Goda A, Shiraishi Y, et al
    Malnutrition in real-world patients hospitalized for heart failure with preserved ejection fraction and its potential impact on generalizability of EMPEROR-Preserved trial.
    Int J Cardiol. 2022 Oct 15. pii: S0167-5273(22)01533.
    PubMed     Abstract available


  228. PROFF J, Merkely B, Papp R, Lenz C, et al
    Closed loop stimulation in patients with chronic heart failure and severe chronotropic incompetence: Responders versus non-responders.
    Int J Cardiol. 2022 Oct 12. pii: S0167-5273(22)01530.
    PubMed     Abstract available


  229. SIMON W, Maria P, Mahabadi AA, Tienush R, et al
    Betablockers reduce oxygen pulse increase and performance in heart failure patients with preserved ejection fraction.
    Int J Cardiol. 2022 Oct 8. pii: S0167-5273(22)01478.
    PubMed     Abstract available


  230. CHEN A, Geng Z, Zhang Y
    Efficacy and safety of early cardiac rehabilitation for patients with heart failure.
    Int J Cardiol. 2022 Oct 5. pii: S0167-5273(22)01471.
    PubMed    


  231. CASTRO-PORTILLO E, Lopez-Izquierdo R, Sanz-Garcia A, Ortega GJ, et al
    Role of prehospital point-of-care N-terminal pro-brain natriuretic peptide in acute life-threatening cardiovascular disease.
    Int J Cardiol. 2022;364:126-132.
    PubMed     Abstract available


    September 2022
  232. LI L, Tu B, Liu S, Zhang Z, et al
    Sex differences in ventricular arrhythmias epidemiology, risk factors, and mortality in congestive heart failure.
    Int J Cardiol. 2022 Sep 28. pii: S0167-5273(22)01415.
    PubMed     Abstract available


  233. PICCINNI C, Dondi L, Calabria S, Ronconi G, et al
    How many and who are patients with heart failure eligible to SGLT2 inhibitors? Responses from the combination of administrative healthcare and primary care databases.
    Int J Cardiol. 2022 Sep 26. pii: S0167-5273(22)01403.
    PubMed     Abstract available


  234. LI X, Zuo C, Chen C, Tian D, et al
    Effectiveness and safety evaluation of sacubitril/valsartan in blood pressure control and clinical outcomes for elderly patients with heart failure and hypertension: A prospective cohort study.
    Int J Cardiol. 2022 Sep 26. pii: S0167-5273(22)01400.
    PubMed     Abstract available


  235. AMIOKA M, Sanada R, Matsumura H, Kinoshita H, et al
    Impact of SGLT2 inhibitors on old age patients with heart failure and chronic kidney disease.
    Int J Cardiol. 2022 Sep 26. pii: S0167-5273(22)01409.
    PubMed     Abstract available


  236. JARJOUR M, Leclerc J, Bouabdallaoui N, Ahnadi C, et al
    Optimization of pharmacotherapies for ambulatory patients with heart failure and reduced ejection fraction is associated with improved outcomes.
    Int J Cardiol. 2022 Sep 26. pii: S0167-5273(22)01408.
    PubMed     Abstract available


  237. ATTAR R, Valentin JB, Andell P, Nielsen RE, et al
    Major adverse cardiovascular events following acute coronary syndrome in patients with bipolar disorder.
    Int J Cardiol. 2022;363:1-5.
    PubMed     Abstract available


  238. STAMATELOPOULOS K, Delialis D, Georgiopoulos G, Tselegkidi MI, et al
    Determining patterns of vascular function and structure in wild-type transthyretin cardiac amyloidosis. A comparative study.
    Int J Cardiol. 2022;363:102-110.
    PubMed     Abstract available


  239. YANG CD, Aihemaiti M, Quan JW, Chen JW, et al
    HbA1c level is associated with the development of heart failure with recovered ejection fraction in hospitalized heart failure patients with type 2 diabetes.
    Int J Cardiol. 2022 Sep 15. pii: S0167-5273(22)01339.
    PubMed     Abstract available


  240. SEFEROVIC PM, Polovina M, Seferovic J, Rosano G, et al
    Strength in synergy: Cardiometabolic effects of sacubitril/valsartan in heart failure and diabetes.
    Int J Cardiol. 2022 Sep 14. pii: S0167-5273(22)01328.
    PubMed    


  241. HIGUCHI S, Orban M, Adamo M, Giannini C, et al
    Sex-specific impact of anthropometric parameters on outcomes after transcatheter edge-to-edge repair for secondary mitral regurgitation.
    Int J Cardiol. 2022 Sep 14. pii: S0167-5273(22)01337.
    PubMed     Abstract available


  242. MAHABADI AA, Anapliotis V, Dykun I, Rassaf T, et al
    Response to: Epicardial adipose tissue in heart failure: A promising therapeutic target.
    Int J Cardiol. 2022 Sep 11. pii: S0167-5273(22)01326.
    PubMed    


  243. MIAO C, Tang ZW, Nie F
    Epicardial adipose tissue in heart failure: A promising therapeutic target.
    Int J Cardiol. 2022 Sep 11. pii: S0167-5273(22)01327.
    PubMed    


  244. PASTORE MC, Mandoli GE, Stefanini A, Ghionzoli N, et al
    Prediction of congestive state in acute and chronic heart failure: The association between NT-proBNP and left atrial strain and its prognostic value.
    Int J Cardiol. 2022 Sep 3. pii: S0167-5273(22)01266.
    PubMed     Abstract available


  245. BURRI H
    Electrical remodeling and super-response with biventricular and conduction system pacing: Can cardiac resynchronization therapy be curative?
    Int J Cardiol. 2022;362:83-84.
    PubMed    


  246. KHAZAEI S, Khazaei M
    Comment on: Prognostic implications of staging cardiac remodeling in patients undergoing cardiac resynchronization therapy.
    Int J Cardiol. 2022;362:152.
    PubMed    


    August 2022
  247. GIL FR, Brida M
    Response to Letter Regarding Article 'Heart failure in adults with congenital heart disease'.
    Int J Cardiol. 2022 Aug 24. pii: S0167-5273(22)01255.
    PubMed    


  248. OGAWA M, Yoshida N, Nakai M, Kanaoka K, et al
    Hospital-associated disability and hospitalization costs for acute heart failure stratified by body mass index- insight from the JROAD/JROAD-DPC database.
    Int J Cardiol. 2022 Aug 24. pii: S0167-5273(22)01254.
    PubMed     Abstract available


  249. GHAJAR A, Ordonez CP, Philips B, Pinzon PQ, et al
    Cardiogenic shock related cardiovascular disease mortality trends in US population: Heart failure vs. acute myocardial infarction as contributing causes.
    Int J Cardiol. 2022 Aug 21. pii: S0167-5273(22)01253.
    PubMed     Abstract available


  250. LI S, Zheng Y, Huang Y, He W, et al
    Association of body mass index and prognosis in patients with HFpEF: A dose-response meta-analysis.
    Int J Cardiol. 2022;361:40-46.
    PubMed     Abstract available


  251. PAPANASTASIOU CA, Bazmpani MA, Kokkinidis DG, Zegkos T, et al
    The prognostic value of right ventricular ejection fraction by cardiovascular magnetic resonance in heart failure: A systematic review and meta-analysis.
    Int J Cardiol. 2022 Aug 9. pii: S0167-5273(22)01175.
    PubMed     Abstract available


  252. TSCHOPE C, Nelki V, Trippel TD, Klingel K, et al
    Safety and usefulness of left ventricular endomyocardial biopsy in new- onset acute heart failure requiring mechanical support by an Impella(R) device.
    Int J Cardiol. 2022 Aug 6. pii: S0167-5273(22)01176.
    PubMed     Abstract available


  253. GARATTI L, Frea S, Bocchino PP, Angelini F, et al
    Sodium nitroprusside in acute heart failure: A multicenter historic cohort study.
    Int J Cardiol. 2022 Aug 6. pii: S0167-5273(22)01177.
    PubMed     Abstract available


  254. LIM HS
    How does protocolization improve outcomes in cardiogenic shock due to end-stage heart failure?
    Int J Cardiol. 2022 Aug 2. pii: S0167-5273(22)01115.
    PubMed     Abstract available


  255. AIMO A, Lupon J, Spitaleri G, Domingo M, et al
    Global warming, renal function and heart failure over 20years.
    Int J Cardiol. 2022 Aug 1. pii: S0167-5273(22)01113.
    PubMed     Abstract available


    July 2022
  256. TANG SS, Wang XJ, Tang CK
    The authors' reply to the letter "CA125 a cause or an effect in heart failure?"
    Int J Cardiol. 2022 Jul 31. pii: S0167-5273(22)01114.
    PubMed    


  257. CHISHIKI T, Nagatomo Y, Saji M, Takei M, et al
    Divergent effect of blood glucose dysregulation on long-term clinical outcome in acute decompensated heart failure: A reappraisal in contemporary practice.
    Int J Cardiol. 2022 Jul 25. pii: S0167-5273(22)01111.
    PubMed     Abstract available


  258. PINTALHAO M, Vasques-Novoa F, Couto-Viana B, Pimentel MJ, et al
    Relaxin-2, pathophysiological insights and outcomes in heart failure with preserved ejection fraction: Findings from the NETDiamond cohort.
    Int J Cardiol. 2022 Jul 20. pii: S0167-5273(22)01106.
    PubMed     Abstract available


  259. AREVALO-LORIDO JC, Carretero-Gomez J
    The circular pathway for the improvement of readmitting heart failure patients.
    Int J Cardiol. 2022 Jul 20. pii: S0167-5273(22)01099.
    PubMed    


  260. AUSTIN DE, Lee DS, Wang CX, Ma S, et al
    Comparison of machine learning and the regression-based EHMRG model for predicting early mortality in acute heart failure.
    Int J Cardiol. 2022 Jul 19. pii: S0167-5273(22)01105.
    PubMed     Abstract available


  261. GODINO C, Scotti A, Marengo A, Battini I, et al
    Effectiveness and cost-efficacy of diuretics home administration via peripherally inserted central venous catheter in patients with end-stage heart failure.
    Int J Cardiol. 2022 Jul 16. pii: S0167-5273(22)01095.
    PubMed     Abstract available


  262. MOOLLA M, Mathew A, John K, Yogasundaram H, et al
    Outcomes of pregnancy in women with hypertrophic cardiomyopathy: A systematic review.
    Int J Cardiol. 2022;359:54-60.
    PubMed     Abstract available


  263. CHENG B, Zhong JP, Fu WJ, Chen HJ, et al
    Microfiber-associated protein 5 (MFAP5): A promising approach to discover new biomarkers for heart failure and cardiac remodeling.
    Int J Cardiol. 2022 Jul 7. pii: S0167-5273(22)01033.
    PubMed    


  264. SHAMAKI GR, Kesiena O, Markson F, Andrew M, et al
    Editorial of "Heart failure with normal LVEF in BIOSTAT-CHF" to International Journal of Cardiology".
    Int J Cardiol. 2022 Jul 1. pii: S0167-5273(22)01021.
    PubMed    


  265. SWARTZ AM, Wamsley C, Crownover E, Tarima S, et al
    Move more and sit less pilot intervention for individuals with heart failure.
    Int J Cardiol. 2022 Jul 1. pii: S0167-5273(22)01023.
    PubMed     Abstract available


    June 2022
  266. YANO M, Nishino M, Ukita K, Kawamura A, et al
    Clinical impact of blood urea nitrogen, regardless of renal function, in heart failure with preserved ejection fraction.
    Int J Cardiol. 2022 Jun 29. pii: S0167-5273(22)01014.
    PubMed     Abstract available


  267. YOUNES AM, Salem M, Maraey A, Nomigolzar S, et al
    Safety outcomes of SGLT2i in the heart failure trials: A systematic review and Meta-analysis.
    Int J Cardiol. 2022 Jun 28. pii: S0167-5273(22)01012.
    PubMed     Abstract available


  268. BAUDO M, D'Ancona G, Trinca F, Rosati F, et al
    Atrioventricular node ablation and pacing for atrial tachyarrhythmias: A meta-analysis of postoperative outcomes.
    Int J Cardiol. 2022 Jun 25. pii: S0167-5273(22)01011.
    PubMed     Abstract available


  269. RABKIN SW
    Heart failure with reduced ejection fraction and diastolic dysfunction (HrEFwDD): Time for a new clinical entity.
    Int J Cardiol. 2022 Jun 24. pii: S0167-5273(22)01008.
    PubMed    


  270. KIM SE, Cho DH, Son JW, Kim JY, et al
    Impact of NT-proBNP on prognosis of acute decompensated chronic heart failure versus de novo heart failure.
    Int J Cardiol. 2022 Jun 23. pii: S0167-5273(22)01007.
    PubMed     Abstract available


  271. COWIE MR, Mourilhe-Rocha R, Chang HY, Volterrani M, et al
    The impact of the COVID-19 pandemic on heart failure management: Global experience of the OPTIMIZE heart failure care network.
    Int J Cardiol. 2022 Jun 21. pii: S0167-5273(22)00922.
    PubMed     Abstract available


  272. EPSTEIN E, Schale S, Brambatti M, You H, et al
    Impact of Transitioning Patients to Oral Diuretics 24 Hours Before Discharge from Heart Failure Hospitalization on 30 Day Outcomes.
    Int J Cardiol. 2022 Jun 20. pii: S0167-5273(22)00930.
    PubMed     Abstract available


  273. CANEPA M, Leporatti L, Persico L, Ameri P, et al
    Frequency, characteristics and prognostic impact of hospital readmissions in elderly patients with heart failure: A population study from 2013 to 2017 in Liguria, Northern Italy.
    Int J Cardiol. 2022 Jun 18. pii: S0167-5273(22)00951.
    PubMed     Abstract available


  274. IMRAN TF, Mohebali D, Lopez D, Goli RR, et al
    NT-proBNP and predictors of event free survival and left ventricular systolic function recovery in peripartum cardiomyopathy.
    Int J Cardiol. 2022;357:48-54.
    PubMed     Abstract available


  275. QIAN Z, Qin C, Zou F, Xue S, et al
    Complete electrical reverse remodeling of native conduction after resynchronization therapies.
    Int J Cardiol. 2022;357:81-87.
    PubMed     Abstract available


  276. SEIDEL F, Opgen-Rhein B, Rentzsch A, Boehne M, et al
    Clinical characteristics and outcome of biopsy-proven myocarditis in children - Results of the German prospective multicentre registry "MYKKE".
    Int J Cardiol. 2022;357:95-104.
    PubMed     Abstract available


  277. JOURY A, Ventura H, Krim SR
    Biomarkers in heart failure: Relevance in the clinical practice.
    Int J Cardiol. 2022 Jun 15. pii: S0167-5273(22)00935.
    PubMed     Abstract available


  278. KIM CH, Hwang IC, Choi HM, Ahn CH, et al
    Differential cardiovascular and renal benefits of SGLT2 inhibitors and GLP1 receptor agonists in patients with type 2 diabetes mellitus.
    Int J Cardiol. 2022 Jun 15. pii: S0167-5273(22)00927.
    PubMed     Abstract available


  279. DE LANGE I, Petersen TB, de Bakker M, Akkerhuis KM, et al
    Heart failure subphenotypes based on repeated biomarker measurements are associated with clinical characteristics and adverse events (Bio-SHiFT study).
    Int J Cardiol. 2022 Jun 14. pii: S0167-5273(22)00919.
    PubMed     Abstract available


  280. SHANG L, Sun H, Tang B, Hou Y, et al
    Metabolic disorders as growing risk factors and comorbidities in heart failure.
    Int J Cardiol. 2022 Jun 2. pii: S0167-5273(22)00822.
    PubMed    


  281. IKEDA S, Shinohara K, Enzan N, Matsushima S, et al
    Serial measurement of B-type natriuretic peptide and future cardiovascular events in patients with type 2 diabetes mellitus without known cardiovascular disease.
    Int J Cardiol. 2022;356:98-104.
    PubMed     Abstract available


  282. SABATINO J, Di Salvo G
    The new pandemic: ACHD HF.
    Int J Cardiol. 2022;356:51-52.
    PubMed    


    May 2022
  283. LEE SY, Jung MH
    Sex-related differences among young adults with heart failure: Does sex matter?
    Int J Cardiol. 2022 May 31. pii: S0167-5273(22)00808.
    PubMed    


  284. HE S, Zhu H, Zhang J, Wu X, et al
    Proteomic analysis of epicardial adipose tissue from heart disease patients with concomitant heart failure with preserved ejection fraction.
    Int J Cardiol. 2022 May 31. pii: S0167-5273(22)00814.
    PubMed     Abstract available


  285. BAUMHOVE L, Tromp J, Figarska S, van Essen BJ, et al
    Heart failure with normal LVEF in BIOSTAT-CHF.
    Int J Cardiol. 2022 May 29. pii: S0167-5273(22)00765.
    PubMed     Abstract available


  286. RIBEIRO GDS, Deresz LF, Salvioni E, Hansen D, et al
    Sensitivity and specificity of different exercise oscillatory ventilation definitions to predict 2-year major adverse cardiovascular outcomes in chronic heart failure patients.
    Int J Cardiol. 2022 May 25. pii: S0167-5273(22)00753.
    PubMed     Abstract available


  287. LIMD Z, LiMD S
    CA125 a cause or an effect in heart failure?
    Int J Cardiol. 2022 May 23. pii: S0167-5273(22)00760.
    PubMed    


  288. MOHAMMED SA
    Editorial: Left, but not right, ventricular status determines heart failure in adults with Ebstein anomaly- a case-control study based on magnetic resonance.
    Int J Cardiol. 2022 May 19. pii: S0167-5273(22)00749.
    PubMed    


  289. STASSEN J, Khidir M, Galloo X, Hirasawa K, et al
    Prognostic implications of staging cardiac remodeling in patients undergoing cardiac resynchronization therapy.
    Int J Cardiol. 2022;355:65-71.
    PubMed     Abstract available


  290. IWATSU K, Ikeda T, Matsumura K, Ashikawa H, et al
    Gap in the prognostic impact of short physical performance battery among phenotypes of heart failure.
    Int J Cardiol. 2022 May 6. pii: S0167-5273(22)00656.
    PubMed     Abstract available


  291. ANGUITA E, Chaparro A, Candel FJ, Ramos-Acosta C, et al
    Biomarkers of stable and decompensated phases of heart failure with preserved ejection fraction.
    Int J Cardiol. 2022 May 6. pii: S0167-5273(22)00655.
    PubMed     Abstract available


    April 2022
  292. FRIGELLI M, Sturla F, Milani V, Ramputi L, et al
    Prognostic value of left atrial strain quantification from 2D ultrasound imaging in post-ischemic heart failure patients: evidence from the REMODEL-HF study.
    Int J Cardiol. 2022 Apr 30. pii: S0167-5273(22)00633.
    PubMed     Abstract available


  293. BASIC C, Rosengren A, Dahlstrom U, Edner M, et al
    Sex-related differences among young adults with heart failure in Sweden.
    Int J Cardiol. 2022 Apr 28. pii: S0167-5273(22)00635.
    PubMed     Abstract available


  294. CIARDULLO S, Cannistraci R, Mazzetti S, Mortara A, et al
    Twenty-year trends in heart failure among U.S. adults, 1999-2018: The growing impact of obesity and diabetes.
    Int J Cardiol. 2022 Apr 26. pii: S0167-5273(22)00578.
    PubMed     Abstract available


  295. YU X
    Heart failure with improved ejection fraction: The current and future in Asian populations.
    Int J Cardiol. 2022 Apr 26. pii: S0167-5273(22)00579.
    PubMed    


  296. CIEPLUCHA A, Trojnarska O, Rajewska-Tabor J, Bartczak-Rutkowska A, et al
    Left, but not right, ventricular status determines heart failure in adults with Ebstein anomaly - A case-control study based on magnetic resonance.
    Int J Cardiol. 2022 Apr 25. pii: S0167-5273(22)00585.
    PubMed     Abstract available


  297. LI L, Zhang Z, Xiong Y, Hu Z, et al
    Prediction of hospital mortality in mechanically ventilated patients with congestive heart failure using machine learning approaches.
    Int J Cardiol. 2022 Apr 25. pii: S0167-5273(22)00581.
    PubMed     Abstract available


  298. BERGONTI M, Spera F, Tijskens M, Bonomi A, et al
    A new prediction model for left ventricular systolic function recovery after catheter ablation of atrial fibrillation in patients with heart failure.
    Int J Cardiol. 2022 Apr 17. pii: S0167-5273(22)00554.
    PubMed     Abstract available


  299. CASTIGLIONE V, Vergaro G, Emdin M
    Targeting precipitants to prevent heart failure hospitalization. Does season matter?
    Int J Cardiol. 2022 Apr 17. pii: S0167-5273(22)00561.
    PubMed    


  300. RIZZO M, Cianflone D, Maranta F
    Treatment of diabetes and heart failure: Facts and hopes.
    Int J Cardiol. 2022 Apr 16. pii: S0167-5273(22)00549.
    PubMed    


  301. YALCIN YC, Veenis JF, Brugts JJ, Antonides CFJ, et al
    Rate of thromboembolic and bleeding events in patients undergoing concomitant aortic valve surgery with left ventricular assist device implantation.
    Int J Cardiol. 2022 Apr 16. pii: S0167-5273(22)00555.
    PubMed     Abstract available


  302. ELBADAWI A, Tan BE, Assaf Y, Megaly M, et al
    Digital health intervention in patients with recent hospitalization for acute heart failure: A systematic review and meta-analysis of randomized trials.
    Int J Cardiol. 2022 Apr 15. pii: S0167-5273(22)00553.
    PubMed     Abstract available


  303. SHOJI S, Kohsaka S, Shiraishi Y, Kohno T, et al
    Conventional medical therapy in heart failure patients eligible for the PARADIGM-HF, DAPA-HF, and SHIFT trials.
    Int J Cardiol. 2022 Apr 11. pii: S0167-5273(22)00500.
    PubMed     Abstract available


  304. MAHABADI AA, Anapliotis V, Dykun I, Hendricks S, et al
    Epicardial fat and incident heart failure with preserved ejection fraction in patients with coronary artery disease.
    Int J Cardiol. 2022 Apr 5. pii: S0167-5273(22)00489.
    PubMed     Abstract available


  305. ROSENTHAL LL, Ulrich SM, Zimmerling L, Brenner P, et al
    Pediatric heart transplantation in infants and small children under 3years of age: Single center experience - "Early and long-term results".
    Int J Cardiol. 2022 Apr 5. pii: S0167-5273(22)00482.
    PubMed     Abstract available


  306. FERREIRA JP, Shah AM, Claggett BL, Pitt B, et al
    Cardiac structure and function and quality of life associations in HFpEF: An analysis from TOPCAT-Americas.
    Int J Cardiol. 2022;352:78-83.
    PubMed     Abstract available


    March 2022
  307. SENGUPTA SP, Okwose NC, MacGowan GA, Jakovljevic DG, et al
    Peak atrio-ventricular mechanics predicts exercise tolerance in heart failure patients.
    Int J Cardiol. 2022 Mar 31. pii: S0167-5273(22)00442.
    PubMed     Abstract available


  308. SU K, Li M, Wang L, Tian S, et al
    Clinical characteristics, predictors, and outcomes of heart failure with improved ejection fraction.
    Int J Cardiol. 2022 Mar 23. pii: S0167-5273(22)00405.
    PubMed     Abstract available


  309. SATO T, Kobayashi Y, Nagai T, Nakatani T, et al
    Long-term preservation of functional capacity and quality of life in advanced heart failure patients with bridge to transplant therapy: A report from Japanese nationwide multicenter registry.
    Int J Cardiol. 2022 Mar 22. pii: S0167-5273(22)00403.
    PubMed     Abstract available


  310. ZHANG Y
    Association between higher serum uric acid levels and plasma N-terminal pro-B-type natriuretic peptide concentrations in patients with coronary artery disease and without overt heart failure.
    Int J Cardiol. 2022 Mar 18. pii: S0167-5273(22)00389.
    PubMed    


  311. ESPERSEN C, Modin D, Platz E, Jensen GB, et al
    Global and regional wall motion abnormalities and incident heart failure in the general population.
    Int J Cardiol. 2022 Mar 15. pii: S0167-5273(22)00386.
    PubMed     Abstract available


  312. AIMO A, Lupon J, Bayes-Genis A, Emdin M, et al
    Urinary NGAL in acute heart failure revisited: the game is not over yet.
    Int J Cardiol. 2022 Mar 14. pii: S0167-5273(22)00382.
    PubMed    


  313. MINISTRINI S
    Could serum carboxyterminal telopeptide of collagen type I (CITP) have a role in the early diagnosis of heart failure with preserved ejection fraction (HFpEF)?
    Int J Cardiol. 2022 Mar 14. pii: S0167-5273(22)00383.
    PubMed    


  314. JAYAGOPAL PB, Sastry SL, Nanjappa V, Abdullakutty J, et al
    Clinical characteristics and 30-day outcomes in patients with acute decompensated heart failure: Results from Indian College of Cardiology National Heart Failure Registry (ICCNHFR).
    Int J Cardiol. 2022 Mar 13. pii: S0167-5273(22)00381.
    PubMed     Abstract available


  315. BRIDA M, Lovric D, Griselli M, Gil FR, et al
    Heart failure in adults with congenital heart disease.
    Int J Cardiol. 2022 Mar 10. pii: S0167-5273(22)00337.
    PubMed     Abstract available


  316. BILLINGSLEY HE, Canada JM, Dixon DL, Kirkman DL, et al
    Midpoint of energy intake, non-fasting time and cardiorespiratory fitness in heart failure with preserved ejection fraction and obesity.
    Int J Cardiol. 2022 Mar 8. pii: S0167-5273(22)00330.
    PubMed     Abstract available


    February 2022
  317. HORIUCHI Y, Wettersten N, van Veldhuisen DJ, Mueller C, et al
    Decongestion, kidney injury and prognosis in patients with acute heart failure.
    Int J Cardiol. 2022 Feb 21. pii: S0167-5273(22)00261.
    PubMed     Abstract available


  318. CHIANG B, Chew DP, De Pasquale CG
    Outcome trial data on sodium glucose cotransporter-2 inhibitors: Putting clinical benefits and risks in perspective.
    Int J Cardiol. 2022;349:96-98.
    PubMed     Abstract available


  319. TINI G, Cuomo A, Battistoni A, Sarocchi M, et al
    Baseline cardio-oncologic risk assessment in breast cancer women and occurrence of cardiovascular events: The HFA/ICOS risk tool in real-world practice.
    Int J Cardiol. 2022;349:134-137.
    PubMed     Abstract available


  320. ROJAS LZ, Gomez-Ochoa SA, Echeverria LE, Bautista-Nino PK, et al
    Circulating DHEA-S levels and major cardiovascular outcomes in chronic Chagas cardiomyopathy: A prospective cohort study.
    Int J Cardiol. 2022;349:90-95.
    PubMed     Abstract available


  321. MANTOVANI A, Bonapace S, Dugo C, Beatrice G, et al
    Association between higher serum uric acid levels and plasma N-terminal pro-B-type natriuretic peptide concentrations in patients with coronary artery disease and without overt heart failure.
    Int J Cardiol. 2022 Feb 12. pii: S0167-5273(22)00248.
    PubMed     Abstract available


  322. DURAN A, De Anda-Duran I, Ventura HO
    The era of heart failure risk prediction models, is it time to test their utility?
    Int J Cardiol. 2022 Feb 9. pii: S0167-5273(22)00218.
    PubMed    


  323. CHARANSONNEY OL
    SGLT-2 inhibitors in frail patients with heart failure.
    Int J Cardiol. 2022 Feb 5. pii: S0167-5273(22)00193.
    PubMed    


  324. GIRERD N
    The growing importance of heart failure in myocardial infarction.
    Int J Cardiol. 2022 Feb 5. pii: S0167-5273(22)00194.
    PubMed    


  325. SALA A, Lorusso R, Alfieri O
    Isolated tricuspid regurgitation: A plea for early correction.
    Int J Cardiol. 2022 Feb 4. pii: S0167-5273(22)00195.
    PubMed     Abstract available


  326. TRAMBAIOLO P, Figliuzzi I, Salvati M, Bertini P, et al
    Ventriculo-arterial coupling in the intensive cardiac care unit: A non-invasive prognostic parameter.
    Int J Cardiol. 2022;348:85-89.
    PubMed     Abstract available


  327. AHMED S, Ahmed A, Radegran G
    The Authors' Reply to the Letter "Plasma tumour and metabolism related biomarkers differentiate PAH from HFpEF-PH may improve long-term prognosis".
    Int J Cardiol. 2022;348:108.
    PubMed    


    January 2022
  328. ROVAI S, Contini M, Sciomer S, Vignati C, et al
    The double anaerobic threshold in heart failure.
    Int J Cardiol. 2022 Jan 25. pii: S0167-5273(22)00136.
    PubMed     Abstract available


  329. DONAL E, L'official G, Kosmala W
    New guidelines for managing chronic heart failure patients and new needs in echocardiography.
    Int J Cardiol. 2022 Jan 21. pii: S0167-5273(22)00125.
    PubMed    


  330. SCRUTINIO D, Guida P, Passantino A, Scalvini S, et al
    Association of improvement in functional capacity after rehabilitation with long-term survival in heart failure.
    Int J Cardiol. 2022 Jan 21. pii: S0167-5273(22)00129.
    PubMed     Abstract available


  331. CHANG GM, Chen JY, Kuo WY, Tung YC, et al
    Associations of continuity and coordination of care with outcomes and costs after discharge among patients with heart failure: A nationwide population-based study.
    Int J Cardiol. 2022 Jan 19. pii: S0167-5273(22)00118.
    PubMed     Abstract available


  332. ZHENG H, Liang J, Chen X, Chen X, et al
    Plasma tumour and metabolism related biomarkers differentiate PAH from HFpEF-PH may improve long-term prognosis.
    Int J Cardiol. 2022;347:64-65.
    PubMed    


  333. CARLUCCIO E, Dini FL, Bitto R, Ciccarelli M, et al
    Benefit from sacubitril/valsartan is associated with hemodynamic improvement in heart failure with reduced ejection fraction: An echocardiographic study.
    Int J Cardiol. 2022 Jan 5. pii: S0167-5273(22)00004.
    PubMed     Abstract available


  334. GIANNONI A, Sciarrone P
    Prognostic impact of diabetes in heart failure: looking back to move forward.
    Int J Cardiol. 2022 Jan 4. pii: S0167-5273(22)00005.
    PubMed    


    December 2021
  335. DRISCOLL A, Romanuick H, Dinh D, Amerena J, et al
    Clinical risk prediction model for 30-day all-cause re-hospitalisation or mortality in patients hospitalised with heart failure.
    Int J Cardiol. 2021 Dec 31. pii: S0167-5273(21)02053.
    PubMed     Abstract available


  336. GIACCARI A, Pontremoli R, Filardi PP
    SGLT-2 inhibitors for treatment of heart failure in patients with and without type 2 diabetes: A practical approach for routine clinical practice.
    Int J Cardiol. 2021 Dec 31. pii: S0167-5273(21)02054.
    PubMed     Abstract available


  337. RIND IA, Cannata A, McDonaugh B, Cassimon B, et al
    Patients hospitalised with heart failure across different waves of the COVID-19 pandemic show consistent clinical characteristics and outcomes.
    Int J Cardiol. 2021 Dec 29. pii: S0167-5273(21)02045.
    PubMed     Abstract available


  338. DE LUCA L, Cicala SD, D'Errigo P, Cerza F, et al
    Impact of age, gender and heart failure on mortality trends after acute myocardial infarction in Italy.
    Int J Cardiol. 2021 Dec 16. pii: S0167-5273(21)02015.
    PubMed     Abstract available


  339. BHATIA HS, Nishimura M, Martinez A, Vanam S, et al
    Systolic dysfunction in patients with methamphetamine use and heart failure with preserved ejection fraction.
    Int J Cardiol. 2021 Dec 15. pii: S0167-5273(21)02016.
    PubMed     Abstract available


  340. ANABA U, Ishola A, Alabre A, Bui A, et al
    Diversity in modern heart failure trials: Where are we, and where are we going.
    Int J Cardiol. 2021 Dec 14. pii: S0167-5273(21)02010.
    PubMed     Abstract available


  341. BALBI C
    Editorial: Transverse aortic constriction-induced heart failure leads to increased levels of circulating microparticles.
    Int J Cardiol. 2021 Dec 13. pii: S0167-5273(21)01995.
    PubMed    


  342. GUAZZI M, Bursi F, Rusconi F
    Lung Biomarkers: a new route for distinguishing pulmonary hypertension due to HFpEF from pulmonary arterial hypertension.
    Int J Cardiol. 2021 Dec 13. pii: S0167-5273(21)01982.
    PubMed    


  343. YANDRAPALLI S, Malik AH, Namrata F, Pemmasani G, et al
    Influence of diabetes mellitus interactions with cardiovascular risk factors on post-myocardial infarction heart failure hospitalizations.
    Int J Cardiol. 2021 Dec 2. pii: S0167-5273(21)01976.
    PubMed     Abstract available


  344. SARDU C, Amarelli C
    Continuous flow left ventricular assist devices and cardiac resynchronization: Friends or foe?
    Int J Cardiol. 2021;344:138-139.
    PubMed    


  345. LIANG Y, Ding R, Wang J, Gong X, et al
    Prediction of response after cardiac resynchronization therapy with machine learning.
    Int J Cardiol. 2021;344:120-126.
    PubMed     Abstract available


    November 2021
  346. KRIM SR
    Use of plasma renin and aldosterone profiles for prognostication in acute heart failure: A step forward but not ready for prime time.
    Int J Cardiol. 2021 Nov 30. pii: S0167-5273(21)01952.
    PubMed    


  347. OSUNDOLIRE S, Naqvi S, Nunes AP, Lapane KL, et al
    Heart failure among US nursing home residents with diabetes mellitus.
    Int J Cardiol. 2021 Nov 23. pii: S0167-5273(21)01777.
    PubMed     Abstract available


  348. KITAI T
    Early intravenous vasodilator therapy in acute decompensated heart failure: Is the time-to-treat concept still applicable in a pre-hospital setting?
    Int J Cardiol. 2021 Nov 20. pii: S0167-5273(21)01859.
    PubMed    


  349. REA F, Iorio A, Barbati G, Bessi R, et al
    Patient adherence to drug treatment in a community based-sample of patients with chronic heart failure.
    Int J Cardiol. 2021 Nov 18. pii: S0167-5273(21)01788.
    PubMed    


  350. FUDIM M, Devaraj S, Chukwurah M, Ajam T, et al
    Prognosis for patients with heart failure and reduced ejection fraction with and without diabetes: A 7 year nationwide veteran administration analysis.
    Int J Cardiol. 2021 Nov 17. pii: S0167-5273(21)01849.
    PubMed     Abstract available


  351. LAMMERS AE, Sprenger KS, Diller GP, Miera O, et al
    Ventricular assist devices in paediatric cardiomyopathy and congenital heart disease: An analysis of the German National Register for Congenital Heart Defects.
    Int J Cardiol. 2021;343:37-44.
    PubMed     Abstract available


  352. GORI M, Marini M, De Maria R, Gonzini L, et al
    Age-related changes in clinical characteristics and outcomes of chronic heart failure outpatients in a cardiology setting. A report from the Italian Network on Heart Failure.
    Int J Cardiol. 2021 Nov 15. pii: S0167-5273(21)01783.
    PubMed     Abstract available


  353. MO M, Xia N, Liao Y
    Letter on "Effects of SGLT2 inhibitors on cardiovascular, renal, and major safety outcomes in heart failure: A meta-analysis of randomized controlled trials".
    Int J Cardiol. 2021 Nov 13. pii: S0167-5273(21)01839.
    PubMed    


  354. TEMPORELLI PL, Arbelo E, Laroche C, Blomstrom-Lundqvist C, et al
    Atrial fibrillation ablation in heart failure: Findings from the ESC-EHRA EORP Atrial Fibrillation Ablation long-term (AFA LT) registry.
    Int J Cardiol. 2021 Nov 11. pii: S0167-5273(21)01779.
    PubMed     Abstract available


  355. PFEIFER P, Zietzer A, Holscher M, Jehle J, et al
    Transverse aortic constriction-induced heart failure leads to increased levels of circulating microparticles.
    Int J Cardiol. 2021 Nov 10. pii: S0167-5273(21)01772.
    PubMed     Abstract available


  356. UDANI K, Chris-Olaiya A, Ohadugha C, Malik A, et al
    Cardiovascular manifestations in hospitalized patients with hemochromatosis in the United States.
    Int J Cardiol. 2021;342:117-124.
    PubMed     Abstract available


  357. FASTNER C, Yuecel G, Rudic B, Schmiel G, et al
    Cardiac Contractility Modulation in Patients with Ischemic versus Non-ischemic Cardiomyopathy: Results from the MAINTAINED Observational Study.
    Int J Cardiol. 2021;342:49-55.
    PubMed     Abstract available


    October 2021
  358. BIEGUS J, Nawrocka-Millward S, Zymlinski R, Fudim M, et al
    Distinct renin/aldosterone activity profiles correlate with renal function, natriuretic response, decongestive ability and prognosis in acute heart failure.
    Int J Cardiol. 2021 Oct 30. pii: S0167-5273(21)01703.
    PubMed     Abstract available


  359. AHMED S, Ahmed A, Radegran G
    Plasma tumour and metabolism related biomarkers AMBP, LPL and Glyoxalase I differentiate heart failure with preserved ejection fraction with pulmonary hypertension from pulmonary arterial hypertension.
    Int J Cardiol. 2021 Oct 25. pii: S0167-5273(21)01690.
    PubMed     Abstract available


  360. HE Z, Yang L, Nie Y, Wang Y, et al
    Effects of SGLT-2 inhibitors on health-related quality of life and exercise capacity in heart failure patients with reduced ejection fraction: A systematic review and meta-analysis.
    Int J Cardiol. 2021 Oct 12. pii: S0167-5273(21)01562.
    PubMed     Abstract available


  361. YOUN JC, Baek SH
    Heart failure risk in younger adults needing more attention.
    Int J Cardiol. 2021 Oct 8. pii: S0167-5273(21)01560.
    PubMed    


  362. ARENJA N, Mueller C, Tomilovskaya E, Koryak Y, et al
    Real-world experience of feasibility and efficacy of electrical muscle stimulation in elderly patients with acute heart failure: A randomized controlled study.
    Int J Cardiol. 2021 Oct 7. pii: S0167-5273(21)01504.
    PubMed     Abstract available


  363. DARDEN D, Ammirati E, Brambatti M, Lin A, et al
    Cardiovascular implantable electronic device therapy in patients with left ventricular assist devices: insights from TRAViATA.
    Int J Cardiol. 2021;340:26-33.
    PubMed     Abstract available


    September 2021
  364. MIRO O, Llorens P, Freund Y, Davison B, et al
    Early intravenous nitroglycerin use in prehospital setting and in the emergency department to treat patients with acute heart failure: Insights from the EAHFE Spanish registry.
    Int J Cardiol. 2021 Sep 17. pii: S0167-5273(21)01470.
    PubMed     Abstract available


  365. DLOUHA D, Ivak P, Netuka I, Novakova S, et al
    The effect of long-term left ventricular assist device support on flow-sensitive plasma microRNA levels.
    Int J Cardiol. 2021;339:138-143.
    PubMed     Abstract available


  366. WEBER C, Hung J, Hickling S, Li I, et al
    Changing age-specific trends in incidence, comorbidities and mortality of hospitalised heart failure in Western Australia between 2001 and 2016.
    Int J Cardiol. 2021 Sep 11. pii: S0167-5273(21)01376.
    PubMed     Abstract available


  367. KAPELIOS CJ, Canepa M, Benson L, Hage C, et al
    Non-cardiology vs. cardiology care of patients with heart failure and reduced ejection fraction is associated with lower use of guideline-based care and higher mortality: Observations from The Swedish Heart Failure Registry.
    Int J Cardiol. 2021 Sep 10. pii: S0167-5273(21)01334.
    PubMed     Abstract available


  368. GUIMARAES GV, Ribeiro F, Castro RE, Roque JM, et al
    Effects of the exercise training on skeletal muscle oxygen consumption in heart failure patients with reduced ejection fraction.
    Int J Cardiol. 2021 Sep 7. pii: S0167-5273(21)01318.
    PubMed     Abstract available


  369. AMARELLI C, Limongelli G
    Cardiac amyloidosis: Watching the tip of the iceberg emerging from the "heart of the sea".
    Int J Cardiol. 2021;338:226-228.
    PubMed    


  370. BODE N, Hochadel M, Andresen D, Zahn R, et al
    Cardiac glycosides are not associated with increased mortality or hospitalization rates in ICD and CRT-ICD patients after adjustment for baseline-characteristics at one-year follow-up: Results from the German DEVICE registry.
    Int J Cardiol. 2021;338:109-114.
    PubMed     Abstract available


    August 2021
  371. MONZO L, Ferrari I, Cicogna F, Tota C, et al
    Sodium-glucose co-transporter-2 inhibitors eligibility in patients with heart failure with reduced ejection fraction.
    Int J Cardiol. 2021 Aug 26. pii: S0167-5273(21)01301.
    PubMed     Abstract available


  372. KANEKO H, Itoh H, Kamiya K, Morita K, et al
    Acute-phase initiation of cardiac rehabilitation and clinical outcomes in hospitalized patients for acute heart failure.
    Int J Cardiol. 2021 Aug 26. pii: S0167-5273(21)01307.
    PubMed     Abstract available


  373. NAKAO K, Yasuda S, Noguchi T, Sumita Y, et al
    Association of hospital performance measures with readmissions for patients with heart failure: A report from JROAD-DPC study.
    Int J Cardiol. 2021 Aug 19. pii: S0167-5273(21)01229.
    PubMed     Abstract available


  374. VINTER N, Frost L, Benjamin EJ
    Heart failure and atrial fibrillation - does heart failure subtype matter?
    Int J Cardiol. 2021 Aug 6. pii: S0167-5273(21)01216.
    PubMed    


  375. TADA A, Nagai T, Omote K, Iwano H, et al
    Performance of the H2FPEF and the HFA-PEFF scores for the diagnosis of heart failure with preserved ejection fraction in Japanese patients: A report from the Japanese multicenter registry.
    Int J Cardiol. 2021 Aug 5. pii: S0167-5273(21)01211.
    PubMed     Abstract available


    July 2021
  376. MATETIC A, Mohamed M, Miller RJH, Kolman L, et al
    Impact of cancer diagnosis on causes and outcomes of 5.9 million US patients with cardiovascular admissions.
    Int J Cardiol. 2021 Jul 29. pii: S0167-5273(21)01197.
    PubMed     Abstract available


  377. ABBOUD A, Gaggin HK
    Heart failure and frailty: Expanding the gender paradox.
    Int J Cardiol. 2021 Jul 24. pii: S0167-5273(21)01190.
    PubMed    


  378. ZHOU Y, Chen S, Rao Z, Yang D, et al
    Prediction of 1-year mortality after heart transplantation using machine learning approaches: A single-center study from China.
    Int J Cardiol. 2021 Jul 13. pii: S0167-5273(21)01169.
    PubMed     Abstract available


  379. NJI MAM, Solomon SD, Chen LY, Shah AM, et al
    Association of heart failure subtypes and atrial fibrillation: Data from the Atherosclerosis Risk in Communities (ARIC) study.
    Int J Cardiol. 2021 Jul 8. pii: S0167-5273(21)01100.
    PubMed     Abstract available


  380. VALERIANOVA A, Malik J, Janeckova J, Kovarova L, et al
    Reduction of arteriovenous access blood flow leads to biventricular unloading in haemodialysis patients.
    Int J Cardiol. 2021;334:148-153.
    PubMed     Abstract available


    June 2021
  381. DE LA ESPRIELLA R, Minana G, Santas E, Nunez G, et al
    Effects of empagliflozin on CA125 trajectory in patients with chronic congestive heart failure.
    Int J Cardiol. 2021 Jun 30. pii: S0167-5273(21)01084.
    PubMed     Abstract available


  382. ISHIWATA S, Matsue Y, Nakamura Y, Dotare T, et al
    Clinical and prognostic values of urinary alpha1-microglobulin as a tubular marker in acute heart failure.
    Int J Cardiol. 2021 Jun 26. pii: S0167-5273(21)01079.
    PubMed     Abstract available


  383. DURAN A, daSilva-deAbreu A, Joury A, Ventura HO, et al
    FGF23 predicts outcomes in heart failure but questions remain unanswered.
    Int J Cardiol. 2021 Jun 19. pii: S0167-5273(21)01034.
    PubMed    


  384. ILONZE OJ, Guglin M
    Vericiguat, organic nitrates, and heart failure in African Americans.
    Int J Cardiol. 2021 Jun 19. pii: S0167-5273(21)01031.
    PubMed     Abstract available


  385. DOLDI PM, Buech J, Orban M, Samson-Himmelstjerna P, et al
    Transcatheter mitral valve repair may increase eligibility for heart transplant listing in patients with end-stage heart failure and severe secondary mitral regurgitation.
    Int J Cardiol. 2021 Jun 19. pii: S0167-5273(21)01029.
    PubMed     Abstract available


  386. KEULARDS DCJ, Bouwmeester S, de Vos AMJ, Dekker LRC, et al
    High microvascular resistance and reduced left atrial strain in patients with coronary microvascular dysfunction: The micro-strain study.
    Int J Cardiol. 2021;333:21-28.
    PubMed     Abstract available


  387. DASILVA-DEABREU A, Lavie CJ, Mehra MR
    Bridging the palliative care chasm in advanced heart failure.
    Int J Cardiol. 2021 Jun 15. pii: S0167-5273(21)00969.
    PubMed    


  388. WANG M, Luo B
    Levosimendan is safe to patients with advanced heart failure and hypotension.
    Int J Cardiol. 2021 Jun 9. pii: S0167-5273(21)00914.
    PubMed    


  389. EMOTO T, Hayashi T, Tabata T, Yamashita T, et al
    Metagenomic analysis of gut microbiota reveals its role in trimethylamine metabolism in heart failure.
    Int J Cardiol. 2021 Jun 5. pii: S0167-5273(21)00962.
    PubMed     Abstract available


  390. LIU L, Lima JAC, Post WS, Szklo M, et al
    Associations of time-varying obesity and metabolic syndrome with risk of incident heart failure and its subtypes: Findings from the Multi-Ethnic Study of Atherosclerosis.
    Int J Cardiol. 2021 Jun 2. pii: S0167-5273(21)00908.
    PubMed     Abstract available


  391. POTRATZ M, Fox H, Rudolph V, Faber L, et al
    Respiratory dyssynchrony is a predictor of prognosis in patients with hypertrophic non-obstructive cardiomyopathy.
    Int J Cardiol. 2021;332:105-112.
    PubMed     Abstract available


    May 2021
  392. AIMO A
    Longitudinal changes in cardiac biomarkers and outcome in heart failure: Sex-related differences.
    Int J Cardiol. 2021 May 18. pii: S0167-5273(21)00839.
    PubMed    


  393. VERGARO G, Aimo A, Taurino E, Del Franco A, et al
    Discharge FGF23 levels predicts one year outcome in patients admitted with acute heart failure.
    Int J Cardiol. 2021 May 18. pii: S0167-5273(21)00840.
    PubMed     Abstract available


  394. SAMUEL TJ, Wei J, Sharif B, Tamarappoo BK, et al
    Diastolic dysfunction in women with ischemia and no obstructive coronary artery disease: Mechanistic insight from magnetic resonance imaging.
    Int J Cardiol. 2021;331:1-7.
    PubMed     Abstract available


  395. GALLI E, Smiseth OA MD, PhD, Aalen JM, Larsen CK, et al
    Prognostic utility of the assessment of diastolic function in patients undergoing cardiac resynchronization therapy.
    Int J Cardiol. 2021;331:144-151.
    PubMed     Abstract available


  396. MACGOWAN GA, Woods A, Robinson-Smith N, Tovey S, et al
    Using existing technology better: Improving outcomes with the HeartWare left ventricular assist device.
    Int J Cardiol. 2021;331:35-39.
    PubMed     Abstract available


  397. SHARIATI F, Baldawi H, Bob-Manuel T
    Editorial: Premature death from heart failure among Aboriginal peoples in the Hunter New England region of new South Wales.
    Int J Cardiol. 2021 May 14. pii: S0167-5273(21)00838.
    PubMed    


  398. KAMIYA K, Adachi T, Iwatsu K, Kamisaka K, et al
    Association between a pre-admission limitation in walking ability and post-discharge adverse outcomes among hospitalized patients with heart failure: Report from a multicenter prospective cohort study.
    Int J Cardiol. 2021 May 12. pii: S0167-5273(21)00832.
    PubMed     Abstract available


  399. SACCO A, Morici N, Villanova L, Viola G, et al
    Withdrawal of active treatments in terminally ill heart failure patients.
    Int J Cardiol. 2021 May 5. pii: S0167-5273(21)00815.
    PubMed     Abstract available


  400. KLEIN HU
    Cardiac resynchronization therapy with- or without defibrillator. Estimating the risk of arrhythmic death or assessing the likelihood of non-arrhythmic mortality?
    Int J Cardiol. 2021;330:82-83.
    PubMed    


    April 2021
  401. SCHREUDER MM, Schuurman A, Akkerhuis KM, Constantinescu AA, et al
    Sex-specific temporal evolution of circulating biomarkers in patients with chronic heart failure with reduced ejection fraction.
    Int J Cardiol. 2021 Apr 30. pii: S0167-5273(21)00804.
    PubMed     Abstract available


  402. GORI M, Claggett B, Senni M, Shah AM, et al
    Combining diastolic dysfunction and natriuretic peptides to risk stratify patients with heart failure with reduced ejection fraction.
    Int J Cardiol. 2021 Apr 19. pii: S0167-5273(21)00664.
    PubMed     Abstract available


  403. AIMO A, Manetti S, Emdin M
    How much is it to mend a broken heart? Results from the US Nationwide Readmission Database.
    Int J Cardiol. 2021;329:150-151.
    PubMed    


  404. MCGEE M, Sugito S, Al-Omary MS, Hartnett D, et al
    Heart failure outcomes in Aboriginal and Torres Strait Islander peoples in the Hunter New England region of New South Wales.
    Int J Cardiol. 2021 Apr 8. pii: S0167-5273(21)00637.
    PubMed     Abstract available


  405. LI X, Zhang Q, Zhu L, Wang G, et al
    Effects of SGLT2 inhibitors on cardiovascular, renal, and major safety outcomes in heart failure: A meta-analysis of randomized controlled trials.
    Int J Cardiol. 2021 Apr 7. pii: S0167-5273(21)00636.
    PubMed     Abstract available


  406. CAO M, Stolen CM, Ahmed R, Schloss EJ, et al
    Small decreases in biventricular pacing percentages are associated with multiple metrics of worsening heart failure as measured from a cardiac resynchronization therapy defibrillator.
    Int J Cardiol. 2021 Apr 1. pii: S0167-5273(21)00632.
    PubMed     Abstract available


  407. QAMRUDDIN S, Ventura HO
    Serial echocardiographic parameters to evaluate prognosis in patients with HFrEF - is it worth the second test?
    Int J Cardiol. 2021;328:141-142.
    PubMed    


  408. REINHOLD J, Papadopoulou C, Baral R, Vassiliou VS, et al
    Iron deficiency for prognosis in acute coronary syndrome - A systematic review and meta-analysis.
    Int J Cardiol. 2021;328:46-54.
    PubMed     Abstract available


  409. COHEN ARAZI H, Chirino D, Costabel JP, Pulmari CA, et al
    Leuko-platelet index predicts thrombotic events in patients with acute coronary syndrome.
    Int J Cardiol. 2021;328:29-34.
    PubMed     Abstract available


    March 2021
  410. JACKSON AO, Rahman GA, Long S
    Attenuating senescence and dead cells accumulation as heart failure therapy: Break the communication networks.
    Int J Cardiol. 2021 Mar 29. pii: S0167-5273(21)00565.
    PubMed    


  411. SURKOVA E, Dimopoulos K, Li W
    Reply to: "Systolic dysfunction of the subpulmonary left ventricle in the systemic right ventricle: late manifestation or subclinical predictor of heart failure?"
    Int J Cardiol. 2021 Mar 27. pii: S0167-5273(21)00621.
    PubMed     Abstract available


  412. LAINSCAK M, Omersa D, Rosano G, Farkas J, et al
    Pharmacotherapy adherence in patients with heart failure: Easier said than done.
    Int J Cardiol. 2021 Mar 27. pii: S0167-5273(21)00555.
    PubMed    


  413. LI Y, Li L, Wang C
    Insulin-like growth factor binding protein 2 might be a novel therapeutic target in the treatment of heart failure.
    Int J Cardiol. 2021 Mar 19. pii: S0167-5273(21)00549.
    PubMed    


  414. COHEN S, Liu A, Abrahamowicz M, Brophy JM, et al
    Reply to "Risk prediction models for heart failure admissions in adults with congenital heart disease: Methodological issues".
    Int J Cardiol. 2021 Mar 19. pii: S0167-5273(21)00482.
    PubMed    


  415. TANG L, Liu J, Zheng J
    Targeting mitochondrial calcium uniporter in heart failure.
    Int J Cardiol. 2021 Mar 16. pii: S0167-5273(21)00485.
    PubMed    


  416. AL-WAKEEL-MARQUARD N, Seidel F, Herbst C, Kuhnisch J, et al
    Diffuse myocardial fibrosis by T1 mapping is associated with heart failure in pediatric primary dilated cardiomyopathy.
    Int J Cardiol. 2021 Mar 15. pii: S0167-5273(21)00480.
    PubMed     Abstract available


  417. GHIO S, Carluccio E, Scardovi AB, Dini FL, et al
    Prognostic relevance of Doppler echocardiographic re-assessment in HFrEF patients.
    Int J Cardiol. 2021;327:111-116.
    PubMed     Abstract available


  418. KOCHAV SM, Raita Y, Fifer MA, Takayama H, et al
    Predicting the development of adverse cardiac events in patients with hypertrophic cardiomyopathy using machine learning.
    Int J Cardiol. 2021;327:117-124.
    PubMed     Abstract available


  419. CARLUCCIO E, Pugliese NR, Biagioli P, Zuchi C, et al
    Global longitudinal strain in heart failure with reduced ejection fraction: Prognostic relevance across disease severity as assessed by automated cluster analysis.
    Int J Cardiol. 2021 Mar 10. pii: S0167-5273(21)00383.
    PubMed     Abstract available


  420. HIGUCHI S, Shibata S, Hasegawa H, Matsuda T, et al
    Reply to the letter to the editor: "Clinical impact of red blood cell transfusion on adverse clinical events in acute heart failure patients with anemia".
    Int J Cardiol. 2021 Mar 4. pii: S0167-5273(21)00458.
    PubMed    


  421. STIENEN S, Ferreira JP, Bar C, Thum T, et al
    Serum microRNAs and antifibrotic response to eplerenone in acute myocardial infarction complicated by systolic dysfunction.
    Int J Cardiol. 2021 Mar 4. pii: S0167-5273(21)00399.
    PubMed     Abstract available


  422. BARISON A, Aimo A, Emdin M
    Cocaine and methamphetamine use and hospitalization for acute heart failure: Epidemiological evidence from a nationwide dataset.
    Int J Cardiol. 2021 Mar 3. pii: S0167-5273(21)00387.
    PubMed    


  423. OLSEN FJ, Biering-Sorensen T
    Right atrial strain: Tapping into a new reservoir of hemodynamic information.
    Int J Cardiol. 2021;326:226-228.
    PubMed    


  424. YEUNG DF, Jiang R, Behnami D, Jue J, et al
    Impact of the updated diastolic function guidelines in the real world.
    Int J Cardiol. 2021;326:124-130.
    PubMed     Abstract available


  425. SAVIRA F, Kompa AR, Edgley AJ, Jucker BM, et al
    RE: Blockade of apoptosis signal-regulating kinase 1 ameliorates cardiac dysfunction in cardiorenal syndrome via enhancing angiogenesis.
    Int J Cardiol. 2021;326:156.
    PubMed    


    February 2021
  426. DAVIS MR, Lee CS, Corcoran A, Gupta N, et al
    Gender differences in the prevalence of frailty in heart failure: A systematic review and meta-analysis.
    Int J Cardiol. 2021 Feb 28. pii: S0167-5273(21)00371.
    PubMed     Abstract available


  427. NITTA G, Inaba O, Kato S, Kono T, et al
    Catheter ablation for atrial fibrillation in patients with congestive heart failure.
    Int J Cardiol. 2021 Feb 26. pii: S0167-5273(21)00369.
    PubMed     Abstract available


  428. PAOLILLO S, Salvioni E, Perrone Filardi P, Bonomi A, et al
    Corrigendum to "Long-term prognostic role of diabetes mellitus and glycemic control in heart failure patients with reduced ejection fraction: Insights from the MECKI Score database" [Int J Cardiol. 2020 Oct 15; 317: 103-110. PMID: 32360652].
    Int J Cardiol. 2021 Feb 25. pii: S0167-5273(21)00354.
    PubMed    


  429. VAN DEN EYNDE J, Santens B, Van De Bruaene A, Budts W, et al
    Systolic dysfunction of the subpulmonary left ventricle in the systemic right ventricle: Late manifestation or subclinical predictor of heart failure?
    Int J Cardiol. 2021 Feb 25. pii: S0167-5273(21)00368.
    PubMed    


  430. RAJDEV K, Lahan S, Wichman T
    Role of pulmonary arterial capacitance in predicting mortality in patients with pulmonary hypertension: A systematic review and meta-analysis.
    Int J Cardiol. 2021 Feb 20. pii: S0167-5273(21)00296.
    PubMed     Abstract available


  431. ELBADAWI A, Dang A, Elgendy IY, Thakker R, et al
    Age-specific trends and outcomes of hospitalizations with acute heart failure in the United States.
    Int J Cardiol. 2021 Feb 17. pii: S0167-5273(21)00284.
    PubMed     Abstract available


  432. HSIAO FC, Lin CP, Tung YC, Chang PC, et al
    Combining sodium-glucose cotransporter 2 inhibitors and angiotensin receptor-neprilysin inhibitors in heart failure patients with reduced ejection fraction and diabetes mellitus: A multi-institutional study.
    Int J Cardiol. 2021 Feb 12. pii: S0167-5273(21)00288.
    PubMed     Abstract available


  433. SCALVINI S, Bernocchi P, Villa S, Paganoni AM, et al
    Treatment prescription, adherence, and persistence after the first hospitalization for heart failure: A population-based retrospective study on 100,785 patients.
    Int J Cardiol. 2021 Feb 11. pii: S0167-5273(21)00267.
    PubMed     Abstract available


  434. PASSINO C, Sciarrone P, Vergaro G, Borrelli C, et al
    Sacubitril-valsartan treatment is associated with decrease in central apneas in patients with heart failure with reduced ejection fraction.
    Int J Cardiol. 2021 Feb 10. pii: S0167-5273(21)00263.
    PubMed     Abstract available


  435. WANG X, Li X
    Clinical impact of red blood cell transfusion on adverse clinical events in acute heart failure patients with anemia.
    Int J Cardiol. 2021 Feb 10. pii: S0167-5273(21)00269.
    PubMed    


  436. SAKANE K, Kanzaki Y, Hoshiga M
    Reply to "Clinical Significance of B-type Natriuretic Peptide in Patient with Acute Decompensated Heart Failure".
    Int J Cardiol. 2021 Feb 10. pii: S0167-5273(21)00272.
    PubMed    


  437. LEGENDRE A, Moatemri F, Kovalska O, Balice-Pasquinelli M, et al
    Responses to exercise training in patients with heart failure. Analysis by oxygen transport steps.
    Int J Cardiol. 2021 Feb 8. pii: S0167-5273(21)00255.
    PubMed     Abstract available


  438. PROUDFOOT C, Studer R, Rajput T, Jindal R, et al
    Real-world effectiveness and safety of sacubitril/valsartan in heart failure: A systematic review.
    Int J Cardiol. 2021 Feb 2. pii: S0167-5273(21)00143.
    PubMed     Abstract available


  439. VERONESE G, Ammirati E, Chen C, Klingel K, et al
    Management perspectives from the 2019 Wuhan international workshop on fulminant myocarditis.
    Int J Cardiol. 2021;324:131-138.
    PubMed     Abstract available


    January 2021
  440. SHETTY S, Malik AH, Ali A, Yang YC, et al
    Characteristics, trends, outcomes, and costs of stimulant-related acute heart failure hospitalizations in the United States.
    Int J Cardiol. 2021 Jan 31. pii: S0167-5273(21)00142.
    PubMed     Abstract available


  441. NOURAEI H, Rabkin SW
    A new approach to the clinical subclassification of heart failure with preserved ejection fraction.
    Int J Cardiol. 2021 Jan 30. pii: S0167-5273(21)00134.
    PubMed     Abstract available


  442. THEUNS DAMJ, Schaer BA, Caliskan K, Hoeks SE, et al
    Application of the heart failure meta-score to predict prognosis in patients with cardiac resynchronization defibrillators.
    Int J Cardiol. 2021 Jan 28. pii: S0167-5273(21)00091.
    PubMed     Abstract available


  443. SABOUR S, Ghajari H
    Risk prediction models for heart failure admissions in adults with congenital heart disease: Methodological issues.
    Int J Cardiol. 2021 Jan 25. pii: S0167-5273(21)00083.
    PubMed    


  444. CAMELI M, Pastore MC, Mandoli GE
    Left atrial strain: A key element for the evaluation of patients with HFpEF.
    Int J Cardiol. 2021;323:197-198.
    PubMed    


  445. SAVIRA F, Edgley AJ, Jucker BM, Willette RN, et al
    RE: Inhibition of apoptosis signal-regulating kinase 1 might be a novel therapeutic target in the treatment of cardiorenal syndrome.
    Int J Cardiol. 2021;323:260.
    PubMed    


  446. WEI WY, Lian ZX, Ji Y, Zhang N, et al
    Blockade of apoptosis signal-regulating kinase 1 ameliorates cardiac dysfunction in cardiorenal syndrome via enhancing angiogenesis.
    Int J Cardiol. 2021;323:205.
    PubMed    


  447. DANI SS, Ganatra S, Vaduganathan M
    Angioedema with sacubitril/valsartan: Trial-level meta-analysis of over 14,000 patients and real-world evidence to date.
    Int J Cardiol. 2021;323:188-191.
    PubMed     Abstract available


  448. IZUMIDA T, Imamura T
    Clinical significance of B-type natriuretic peptide in patient with acute decompensated heart failure.
    Int J Cardiol. 2021 Jan 4. pii: S0167-5273(20)34326.
    PubMed    


  449. GALLO-BERNAL S, Calixto CA, Molano-Gonzalez N, Moreno MPD, et al
    Impact of a pharmacist-based multidimensional intervention aimed at decreasing the risk of hyperkalemia in heart failure patients: A Latin-American experience.
    Int J Cardiol. 2021 Jan 4. pii: S0167-5273(20)34329.
    PubMed     Abstract available


  450. KUMAR V, Ryu AJ, Manduca A, Rao C, et al
    Cardiac MRI demonstrates compressibility in healthy myocardium but not in myocardium with reduced ejection fraction.
    Int J Cardiol. 2021;322:278-283.
    PubMed     Abstract available


  451. RYU AJ, Kumar V, Borlaug BA, Manduca A, et al
    Systolic-to-diastolic myocardial volume ratio as a novel imaging marker of cardiomyopathy.
    Int J Cardiol. 2021;322:272-277.
    PubMed     Abstract available


    December 2020
  452. KAWADA T
    Risk of heart failure and prognosis in patients with atrial fibrillation.
    Int J Cardiol. 2020 Dec 31. pii: S0167-5273(20)34316.
    PubMed    


  453. IMAMURA T
    Therapeutic strategy for the patients with Takayasu arteritis and heart failure.
    Int J Cardiol. 2020 Dec 31. pii: S0167-5273(20)34318.
    PubMed    


  454. MAGGIONI AP
    How to appropriately update practicing clinicians on innovations in heart failure therapy waiting for the new version of the guidelines?
    Int J Cardiol. 2020 Dec 24. pii: S0167-5273(20)34290.
    PubMed    


  455. PESTELLI G, Fiorencis A, Trevisan F, Luisi GA, et al
    New measures of right ventricle-pulmonary artery coupling in heart failure: An all-cause mortality echocardiographic study.
    Int J Cardiol. 2020 Dec 22. pii: S0167-5273(20)34305.
    PubMed     Abstract available


  456. AGARWAL A, Mohanan PP, Kondal D, Baldridge A, et al
    Effect of a quality improvement intervention for acute heart failure in South India: An interrupted time series study.
    Int J Cardiol. 2020 Dec 21. pii: S0167-5273(20)34296.
    PubMed     Abstract available


  457. GAU SY
    Confusing heart failure ischemic etiology prevalence trend and the definition of composite events.
    Int J Cardiol. 2020 Dec 14. pii: S0167-5273(20)34276.
    PubMed    


  458. KWOK CS, Abramov D, Parwani P, Ghosh RK, et al
    Cost of inpatient heart failure care and 30-day readmissions in the United States.
    Int J Cardiol. 2020 Dec 12. pii: S0167-5273(20)34268.
    PubMed     Abstract available


  459. TAKAHAMA H, Izumi C
    Palliative care for patients with advanced heart failure: When is the optimal timing of advanced care planning?
    Int J Cardiol. 2020 Dec 7. pii: S0167-5273(20)34251.
    PubMed    


  460. VOLPE M, Bauersachs J, Bayes-Genis A, Butler J, et al
    Sacubitril/valsartan for the management of heart failure: A perspective viewpoint on current evidence.
    Int J Cardiol. 2020 Dec 7. pii: S0167-5273(20)34242.
    PubMed     Abstract available


  461. SAKANE K, Kanzaki Y, Tsuda K, Maeda D, et al
    Disproportionately low BNP levels in patients of acute heart failure with preserved vs. reduced ejection fraction.
    Int J Cardiol. 2020 Dec 3. pii: S0167-5273(20)34235.
    PubMed     Abstract available


  462. CHIONCEL O, Ambrosy AP
    Improving adherence to guideline-directed medical therapies and outcomes in the developing world: A call to end global inequities in heart failure.
    Int J Cardiol. 2020 Dec 2. pii: S0167-5273(20)34230.
    PubMed    


  463. PAN J, Wang L, Sun Y
    Inhibition of apoptosis signal-regulating kinase 1 might be a novel therapeutic target in the treatment of cardiorenal syndrome.
    Int J Cardiol. 2020;320:139.
    PubMed    


    November 2020
  464. FERNANDEZ-MARTINEZ J, Romero-Correa M, Salamanca-Bautista P, Aramburu-Bodas O, et al
    Prevalence of advanced heart failure and use of palliative care in admitted patients: Findings from the EPICTER study.
    Int J Cardiol. 2020 Nov 7. pii: S0167-5273(20)34076.
    PubMed     Abstract available


  465. WANG Y, Tse G, Roever L, Liu T, et al
    Sacubitril/valsartan in the treatment of cancer therapy-related cardiac dysfunction.
    Int J Cardiol. 2020;318:130.
    PubMed    


    October 2020
  466. SCHWARTZ B, Schou M, Gislason GH, Kober L, et al
    Prevalence and incidence of various cancer subtypes in patients with heart failure vs matched controls.
    Int J Cardiol. 2020 Oct 31. pii: S0167-5273(20)34065.
    PubMed    


  467. PUGLIESE NR, Rosada J, Masi S
    Train the brain to preserve the heart: the link between education and heart failure.
    Int J Cardiol. 2020 Oct 30. pii: S0167-5273(20)34057.
    PubMed    


  468. RAVAL AN, Johnston PV, Duckers HJ, Cook TD, et al
    Point of care, bone marrow mononuclear cell therapy in ischemic heart failure patients personalized for cell potency: 12-month feasibility results from CardiAMP heart failure roll-in cohort.
    Int J Cardiol. 2020 Oct 19. pii: S0167-5273(20)33996.
    PubMed     Abstract available


  469. ZHANG Y, Fan P, Zhang H, Ma W, et al
    Clinical characteristics and outcomes of chronic heart failure in adult Takayasu arteritis: A cohort study of 163 patients.
    Int J Cardiol. 2020 Oct 18. pii: S0167-5273(20)33984.
    PubMed     Abstract available


  470. HARIKRISHNAN S, Jeemon P, Ganapathi S, Agarwal A, et al
    Five-year mortality and readmission rates in patients with heart failure in India: Results from the Trivandrum heart failure registry.
    Int J Cardiol. 2020 Oct 10. pii: S0167-5273(20)33921.
    PubMed     Abstract available


  471. LEE SY, Kim HL, Kim MA, Park JJ, et al
    Obesity paradox in Korean male and female patients with heart failure: A report from the Korean heart failure registry.
    Int J Cardiol. 2020 Oct 9. pii: S0167-5273(20)33922.
    PubMed     Abstract available


  472. SHARMA K, Premchand RK, Mittal S, Monteiro R, et al
    Long-term follow-up of patients with heart failure and reduced ejection receiving autonomic regulation therapy in the ANTHEM-HF pilot study.
    Int J Cardiol. 2020 Oct 7. pii: S0167-5273(20)33902.
    PubMed     Abstract available


  473. PANA TA, Mohamed MO, Clark AB, Fahy E, et al
    Revascularisation therapies improve the outcomes of ischemic stroke patients with atrial fibrillation and heart failure.
    Int J Cardiol. 2020 Oct 3. pii: S0167-5273(20)33906.
    PubMed     Abstract available


  474. LIAO LZ, Zhuang XD, Zhang SZ, Liao XX, et al
    Education and heart failure: New insights from the atherosclerosis risk in communities study and mendelian randomization study.
    Int J Cardiol. 2020 Oct 2. pii: S0167-5273(20)33898.
    PubMed     Abstract available


  475. ZHONG P, Yuan M, Kong B, Huang H, et al
    ASK-1, a new target in treating cardiorenal syndrome (CRS).
    Int J Cardiol. 2020;316:208.
    PubMed    


  476. SAVIRA F, Kompa AR, Edgley AJ, Jucker BM, et al
    RE: ASK1, a new target in treating cardiorenal syndrome (CRS).
    Int J Cardiol. 2020;316:207.
    PubMed    


    September 2020
  477. SHIBATA N, Kondo T, Kazama S, Kimura Y, et al
    Impact of predictive value of Fibrosis-4 index in patients hospitalized for acute heart failure.
    Int J Cardiol. 2020 Sep 29. pii: S0167-5273(20)33837.
    PubMed     Abstract available


  478. SURKOVA E, Segura T, Dimopouosl K, Bispo D, et al
    Systolic dysfunction of the subpulmonary left ventricle is associated with the severity of heart failure in patients with a systemic right ventricle.
    Int J Cardiol. 2020 Sep 25. pii: S0167-5273(20)33832.
    PubMed     Abstract available


  479. AMMIRATI E, Brambatti M, Braun OO, Shah P, et al
    Outcome of patients on heart transplant list treated with a continuous-flow left ventricular assist device: Insights from the TRans-Atlantic registry on VAd and TrAnsplant (TRAViATA).
    Int J Cardiol. 2020 Sep 17. pii: S0167-5273(20)33807.
    PubMed     Abstract available


  480. BRIDA M
    Heart transplantation in adult congenital heart disease: Importance of timely referral.
    Int J Cardiol. 2020 Sep 14. pii: S0167-5273(20)33822.
    PubMed    


    August 2020
  481. MERAS P, Riesgo-Gil F, Rybicka J, Barradas-Pires A, et al
    Heart transplantation at a single tertiary adult congenital heart disease centre: Too little, too late?
    Int J Cardiol. 2020 Aug 13. pii: S0167-5273(20)33574.
    PubMed     Abstract available


  482. SANDERSON JE, Fang F
    Cardiac cycle time intervals are back again.
    Int J Cardiol. 2020;312:87-88.
    PubMed    


    July 2020
  483. ALKHALIL M, Kearney A, MacElhatton D, Fergie R, et al
    The prognostic role of mid-range ejection fraction in ST-segment elevation myocardial infarction.
    Int J Cardiol. 2020 Jul 15. pii: S0167-5273(20)33449.
    PubMed     Abstract available


    April 2020
  484. LEE EC, McNitt S, Martens J, Bruckel JT, et al
    Long-term milrinone therapy as a bridge to heart transplantation: Safety, efficacy, and predictors of failure.
    Int J Cardiol. 2020 Apr 19. pii: S0167-5273(19)34902.
    PubMed     Abstract available


    March 2020
  485. GAVAZZONI M, Taramasso M, Zuber M, Pozzoli A, et al
    Functional mitral regurgitation and cardiac resynchronization therapy in the "era" of trans-catheter interventions: Is it time to move from a staged strategy to a tailored therapy?
    Int J Cardiol. 2020 Mar 28. pii: S0167-5273(19)35293.
    PubMed     Abstract available


    February 2020
  486. RASHID M, Curzen N, Kinnaird T, Lawson CA, et al
    Baseline risk, timing of invasive strategy and guideline compliance in NSTEMI: Nationwide analysis from MINAP.
    Int J Cardiol. 2020;301:7-13.
    PubMed     Abstract available


  487. LAHUERTA C, Menao S, Gracia-Gutierrez A, Bueno-Juana E, et al
    Diagnosis of genetic amyloidosis through the analysis of transthyretin gene mutation using high-resolution melting.
    Int J Cardiol. 2020;301:220-225.
    PubMed     Abstract available


  488. CAZZOLI I, Gunturiz-Beltran C, Guarguagli S, Alonso-Gonzalez R, et al
    Catheter ablation for patients with end-stage complex congenital heart disease or cardiomyopathy considered for transplantation: Trials and tribulations.
    Int J Cardiol. 2020;301:127-134.
    PubMed     Abstract available


    January 2020
  489. SPEE RF, Niemeijer VM, Schoots T, Tuinenburg A, et al
    High intensity interval training after cardiac resynchronization therapy: An explorative randomized controlled trial.
    Int J Cardiol. 2020;299:169-174.
    PubMed     Abstract available


    December 2019
  490. GRAMEGNA M, Beneduce A, Bertoldi LF, Pagnesi M, et al
    Impella RP support in refractory right ventricular failure complicating acute myocardial infarction with unsuccessful right coronary artery revascularization.
    Int J Cardiol. 2019 Dec 13. pii: S0167-5273(19)35516.
    PubMed     Abstract available


    October 2019
  491. GARCIA R, Boveda S, Defaye P, Sadoul N, et al
    Early mortality after implantable cardioverter defibrillator: Incidence and associated factors.
    Int J Cardiol. 2019 Oct 30. pii: S0167-5273(19)33062.
    PubMed     Abstract available


    June 2019
  492. BACKHAUS SJ, Kowallick JT, Stiermaier T, Lange T, et al
    Atrioventricular mechanical coupling and major adverse cardiac events in female patients following acute ST elevation myocardial infarction.
    Int J Cardiol. 2019 Jun 16. pii: S0167-5273(19)30773.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Chronic Heart Failure is free of charge.